{"content":"<li class=\"n-box-item date-title\" data-end=\"1511326799\" data-start=\"1511240400\" data-txt=\"Monday, December 23, 2019\">Tuesday, November 21, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3314003\" data-ts=\"1511314453\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PDFS\" target=\"_blank\">PDFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314003-pdf-solutions-consol-energy-spin-off-to-join-smallcap-600\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PDF Solutions, Consol Energy spin-off to join SmallCap 600</a></h4><ul>   <li>PDF Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/PDFS' title='PDF Solutions, Inc.'>PDFS</a>) is <a href=\"https://www.spice-indices.com/idpfiles/spice-assets/resources/public/documents/619160_cnxspinboxdiscr.pdf?force_download=true\" target=\"_blank\">replacing Black Box</a> (NASDAQ:<a href='https://seekingalpha.com/symbol/BBOX' title='Black Box Corporation'>BBOX</a>) in the S&amp;P SmallCap 600, S&amp;P says, with Black Box no longer representative of the small-cap market space (it has a market cap below $60M).</li>    <li>Black Box finished the regular session <font color='green'>up 15.3%</font> and postmarket trading <font color='green'>up 4.7%</font>.</li>    <li>In another move tied to Consol Energy's (NYSE:<a href='https://seekingalpha.com/symbol/CNX' title='CNX Resources Corporation'>CNX</a>) <a href=\"https://seekingalpha.com/news/3306396-consol-energy-sets-split-coal-natural-gas-producers-nov-29\" target=\"_blank\">separation into two publicly traded companies</a>, the new Consol Energy (the former Consol Mining, (NYSE:<a href='https://seekingalpha.com/symbol/CEIX' title='CONSOL Energy Inc.'>CEIX</a>)) will replace Iconix Brand Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ICON' title='Iconix Brand Group, Inc.'>ICON</a>) in the SmallCap 600.</li>    <li>After the spin-off, the newly named CNX Resources will stay in the MidCap 400 and be reclassified into the Oil &amp; Gas Exploration and Production area.</li>    <li>Iconix finished the regular session <font color='green'>up 12.3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3314003\" data-linked=\"PDF Solutions, Consol Energy spin-off to join SmallCap 600\" data-tweet=\"$PDFS $PDFS $BBOX - PDF Solutions, Consol Energy spin-off to join SmallCap 600 https://seekingalpha.com/news/3314003-pdf-solutions-consol-energy-spin-off-to-join-smallcap-600?source=tweet\" data-url=\"https://seekingalpha.com/news/3314003-pdf-solutions-consol-energy-spin-off-to-join-smallcap-600\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313996\" data-ts=\"1511308413\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TIVO\" target=\"_blank\">TIVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313996-tivoplus-6_8-itc-rules-comcast-infringed-on-patents\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TiVo +6.8% as ITC rules Comcast infringed on patents</a></h4><ul>   <li>TiVo (NASDAQ:<a href='https://seekingalpha.com/symbol/TIVO' title='TiVo Inc.'>TIVO</a>) is rallying strong after hours, <font color='green'>up 6.8%</font>, after an International Trade Commission ruling saying Comcast (NASDAQ:<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>) <a href=\"https://www.marketwatch.com/story/tivo-shares-rally-as-federal-ruling-says-comcast-infringed-patents-2017-11-21\" target=\"_blank\">violated two of its patents</a>.</li>    <li>Comcast's set-top boxes infringed on the patents of TV-guide company Rovi Corp., now part of TiVo.</li>    <li>The ITC issued an exclusion order banning Comcast from importing and selling infringing X1 boxes, TiVo says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3313996\" data-linked=\"TiVo +6.8% as ITC rules Comcast infringed on patents\" data-tweet=\"$TIVO $TIVO $CMCSA - TiVo +6.8% as ITC rules Comcast infringed on patents https://seekingalpha.com/news/3313996-tivoplus-6_8-itc-rules-comcast-infringed-on-patents?source=tweet\" data-url=\"https://seekingalpha.com/news/3313996-tivoplus-6_8-itc-rules-comcast-infringed-on-patents\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313995\" data-ts=\"1511307992\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSY\" target=\"_blank\">SSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313995-sunlink-health-systems-launches-2_5m-buyback-tender-sharesplus-5_3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunLink Health Systems launches $2.5M buyback tender; shares +5.3%</a></h4><ul>   <li>SunLink Health Systems (NYSEMKT:<a href='https://seekingalpha.com/symbol/SSY' title='SunLink Health Systems, Inc'>SSY</a>) has launched a tender offer to <a href=\"https://seekingalpha.com/pr/17009177-sunlink-health-systems-inc-announces-commencement-tender-offer-repurchase-1562-500-common\" target=\"_blank\">buy back up to 1,562,500</a> of its common shares.</li>    <li>Shares are <font color='green'>up 5.3% </font>after hours.</li>    <li>The offer comes at $1.60/share, making for an aggregate purchase price of $2.5M. Shares closed yesterday at $1.49 and finished up 2% today to $1.52; postmarket quotes are coming at $1.60.</li>    <li>The buyback covers about 17.05% of outstanding common shares. Officers and directors expect to tender 2,136,963 shares in connection with the offer.</li>    <li>It will be funded with part of the company's $8.6M in unrestricted cash.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3313995\" data-linked=\"SunLink Health Systems launches $2.5M buyback tender; shares +5.3%\" data-tweet=\"$SSY - SunLink Health Systems launches $2.5M buyback tender; shares +5.3% https://seekingalpha.com/news/3313995-sunlink-health-systems-launches-2_5m-buyback-tender-sharesplus-5_3?source=tweet\" data-url=\"https://seekingalpha.com/news/3313995-sunlink-health-systems-launches-2_5m-buyback-tender-sharesplus-5_3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313994\" data-ts=\"1511307548\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SE\" target=\"_blank\">SE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313994-sea-limited-declines-postmarket-amid-127m-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sea Limited declines postmarket amid $127M loss</a></h4><ul>   <li>Sea Limited (NYSE:<a href='https://seekingalpha.com/symbol/SE' title='Sea Ltd'>SE</a>) ADRs are <font color='red'>off 1.9%</font> in postmarket trade after posting its <a href=\"https://seekingalpha.com/news/3313988-sea-reports-q3-results\" target=\"_blank\">first earnings report</a> since an Oct. 20 initial public offering.</li>    <li>GAAP revenues were $94.1M and adjusted net loss came to $127.1M. Revenues with addbacks of digital entertainment deferred revenue and e-commerce commission income rose 73%, to $151.7M.</li>    <li>In Digital Entertainment, Garena quarterly active users were up 54% Y/Y to 69M, monthly active users in the last month up 61% to 42.7M, and quarterly paying users rose 38% to 6.5M.</li>    <li>In E-Commerce, gross merchandise value at Shopee rose 219%  Y/Y to $1.065B. Gross orders were up 204% to 65.9M.</li>    <li>Cash and equivalents came to $581.5M, not including proceeds of $939.9M from the Oct. 20 IPO.</li>    <li>For the full year, it expects GAAP revenue (plus change in Digital Entertainment deferred revenue and E-Commerce commission income) to be $540M-$550M, growth of 53-56% Y/Y.</li>    <li><a href=\"http://mms.prnasia.com/SE/20171121/default.aspx\" target=\"_blank\">Conference call</a> to come at 7 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17009194-sea-limited-reports-third-quarter-2017-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3313994\" data-linked=\"Sea Limited declines postmarket amid $127M loss\" data-tweet=\"$SE - Sea Limited declines postmarket amid $127M loss https://seekingalpha.com/news/3313994-sea-limited-declines-postmarket-amid-127m-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3313994-sea-limited-declines-postmarket-amid-127m-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313989\" data-ts=\"1511305523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRT\" target=\"_blank\">CPRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313989-copart-beats-0_06-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Copart beats by $0.06, beats on revenue</a></h4><ul><li>Copart (NASDAQ:<a href='https://seekingalpha.com/symbol/CPRT' title='Copart, Inc.'>CPRT</a>): Q1 EPS of $0.33 <font color='green'>beats by $0.06</font>.</li><li>Revenue of $419.17M (+21.2% Y/Y) <font color='green'>beats by $38.13M</font>.</li><li>Shares <font color='green'>+2%</font> AH.</li><li><a href='https://seekingalpha.com/pr/17009196-copart-reports-first-quarter-fiscal-2018-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3313989\" data-linked=\"Copart beats by $0.06, beats on revenue\" data-tweet=\"$CPRT - Copart beats by $0.06, beats on revenue https://seekingalpha.com/news/3313989-copart-beats-0_06-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3313989-copart-beats-0_06-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313986\" data-ts=\"1511305038\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRVL\" target=\"_blank\">MRVL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313986-bloomberg-starboard-to-vote-for-marvell-cavium-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Starboard to vote for Marvell-Cavium deal</a></h4><ul>   <li>Major Marvell Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/MRVL' title='Marvell Technology Group, Ltd.'>MRVL</a>) stakeholder Starboard Value says it's going to vote for the <a href=\"https://seekingalpha.com/news/3313424-marvell-confirms-6b-deal-cavium\" target=\"_blank\">$6B merger with Cavium</a> (CAVM), according to Bloomberg.</li>    <li>Marvell confirmed the cash and stock deal yesterday, valuing Cavium at $80/share.</li>    <li>As of two days ago, Starboard reported holding about 6.9% of Marvell.</li>    <li>Cavium shares are <font color='green'>up 14.8%</font> over the past two days since news of the deal broke, and <font color='green'>rose 3.8%</font> today. Marvell shares are <font color='green'>up 12.7%</font> over the two days and finished <font color='green'>up 7.8%</font> today.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3313986\" data-linked=\"Bloomberg: Starboard to vote for Marvell-Cavium deal\" data-tweet=\"$MRVL - Bloomberg: Starboard to vote for Marvell-Cavium deal https://seekingalpha.com/news/3313986-bloomberg-starboard-to-vote-for-marvell-cavium-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3313986-bloomberg-starboard-to-vote-for-marvell-cavium-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313982\" data-ts=\"1511303785\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313982-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/TIVO' title='TiVo Inc.'>TIVO</a> <font color='green'>+7.6%</font>. <a href='https://seekingalpha.com/symbol/GME' title='GameStop Corp.'>GME</a> <font color='green'>+4.3%</font>. <a href='https://seekingalpha.com/symbol/AXTA' title='Axalta Coating Systems'>AXTA</a> <font color='green'>+3.6%</font>. <a href='https://seekingalpha.com/symbol/HAIN' title='The Hain Celestial Group, Inc.'>HAIN</a> <font color='green'>+2.2%</font>. <a href='https://seekingalpha.com/symbol/EMES' title='Emerge Energy Services LP'>EMES</a> <font color='green'>+2.0%</font>.</li>     <li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/GES' title='Guess? Inc.'>GES</a> <font color='red'>-12.0%</font>. <a href='https://seekingalpha.com/symbol/CAL' title='Caleres, Inc.'>CAL</a> <font color='red'>-9.7%</font>. <a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a>&nbsp;<font color='red'>-7.6%</font><a href='https://seekingalpha.com/symbol/HPE' title='Hewlett Packard Enterprise'>HPE</a> <font color='red'>-6.1%</font>. <a href='https://seekingalpha.com/symbol/BZUN' title='Baozun'>BZUN</a>&nbsp;<font color='red'>-4.9</font><font color='red'>%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3313982\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$TIVO $GME $AXTA - After Hours Gainers / Losers https://seekingalpha.com/news/3313982-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3313982-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313980\" data-ts=\"1511303346\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXTA\" target=\"_blank\">AXTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313980-axalta-flips-to-green-on-reuters-report-of-nippon-paint-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Axalta flips to green on Reuters report of Nippon Paint offer</a></h4><ul>     <li>Axalta Coating Systems (NYSE:<a href='https://seekingalpha.com/symbol/AXTA' title='Axalta Coating Systems'>AXTA</a>), down as much as 14% after-hours following news that merger talks with Akzo Nobel (<a href='https://seekingalpha.com/symbol/AKZOF' title='AKZO NOBEL NV ORD NEW'>OTCQX:AKZOF</a>, <a href='https://seekingalpha.com/symbol/AKZOY' title='Akzo Nobel N.V. ADR'>OTCQX:AKZOY</a>) had <a href=\"https://seekingalpha.com/news/3313958-axalta-akzo-nobel-talks-collapse-axta-14-percent\" target=\"_blank\">collapsed</a>, turns <font color='green'>+2.9%</font> as Reuters reports AXTA <a href=\"https://www.reuters.com/article/us-axalta-m-a-nipponpaint-exclusive/exclusive-nippon-offer-prompted-axalta-to-end-akzo-nobel-merger-talks-source-idUSKBN1DL2SH\" target=\"_blank\">received another offer</a>.</li>     <li>Japan&rsquo;s Nippon Paint Holdings made an all-cash offer today to acquire AXTA, which caused the U.S. company to cancel talks with Akzo, according to the report.</li>     <li>Nippon&rsquo;s offer came at a premium to where Axalta shares ended trading yesterday, Reuters says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3313980\" data-linked=\"Axalta flips to green on Reuters report of Nippon Paint offer\" data-tweet=\"$AXTA $AXTA $AKZOF - Axalta flips to green on Reuters report of Nippon Paint offer https://seekingalpha.com/news/3313980-axalta-flips-to-green-on-reuters-report-of-nippon-paint-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3313980-axalta-flips-to-green-on-reuters-report-of-nippon-paint-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313979\" data-ts=\"1511302694\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRM\" target=\"_blank\">CRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313979-salesforceminus-1_1-after-q3-beats-mixed-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Salesforce -1.1% after Q3 beats, mixed guidance</a></h4><ul><li>        Salesforce (NYSE:<a href='https://seekingalpha.com/symbol/CRM' title='Salesforce.com, Inc.'>CRM</a>) shares are&nbsp;<font color='red'>down 1.1%</font>&nbsp;aftermarket after Q3 results that beat revenue and EPS estimates but featured mixed guidance. Q4 guidance has revenue from $2.801B to $2.811B (consensus: $2.79B) with EPS from $0.32 to $0.33 (consensus: $0.34).</li><li>               In-line FY19 guidance has revenue from $12.45B to $12.50B compared to the $12.48B consensus.&nbsp;</li><li>               Key metrics: Subscription and support revenue, $2.49B (+25% Y/Y); Professional services and other revenue, $194M (+20%); deferred revenue, $4.39B (+24%); unbilled deferred revenue, $11.5B (+34%).&nbsp;</li><li>               Financials: Cash from operations, $126M (-18%); cash and equivalents, $3.63B; operating expenses, $1.85B. &nbsp;&nbsp;&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17009033-salesforce-announces-record-third-quarter-revenue-raises-full-year-fiscal-2018-revenue\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3313948-salesforce-com-beats-0_02-beats-revenue\" target=\"_blank\">Salesforce.com beats by $0.02, beats on revenue</a> (Nov. 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3313979\" data-linked=\"Salesforce -1.1% after Q3 beats, mixed guidance\" data-tweet=\"$CRM - Salesforce -1.1% after Q3 beats, mixed guidance https://seekingalpha.com/news/3313979-salesforceminus-1_1-after-q3-beats-mixed-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3313979-salesforceminus-1_1-after-q3-beats-mixed-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313972\" data-ts=\"1511301502\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HPE\" target=\"_blank\">HPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313972-hewlett-packard-enterpriseminus-6-on-q4-beats-downside-guidance-ceo-change\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hewlett Packard Enterprise -6% on Q4 beats, downside guidance, CEO change</a></h4><ul><li>        Hewlett Packard Enterprise (NYSE:<a href='https://seekingalpha.com/symbol/HPE' title='Hewlett Packard Enterprise'>HPE</a>) shares are&nbsp;<font color='red'>down 6%&nbsp;</font>aftermarket following Q4 results that beat EPS and revenue estimates but included downside guidance.</li><li>               Q1 guidance has EPS from $0.20 to $0.24 (consensus: $0.27) and FY18 guidance has EPS from $1.15 to $1.25 (consensus: $1.20).&nbsp;</li><li>               Enterprise Group revenue was up 1% on the year in constant currency to $6.9B with a 10.6% operating margin. Servers revenue fell 5%, Storage was up 5%, Networking was up 21%, and Technology Services revenue grew 2%.&nbsp;</li><li>               Financial Services revenue was up 24% to $1B.&nbsp;&nbsp;</li><li>               The company <a href=\"https://seekingalpha.com/pr/17009057-hewlett-packard-enterprise-announces-antonio-neri-succeed-meg-whitman-chief-executive-officer\" target=\"_blank\">announces </a>that current President Antonio Neri will become President and CEO effective February 1. Current CEO Meg Whitman will remain on the board of directors.&nbsp;&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17009049-hpe-reports-fiscal-2017-full-year-fourth-quarter-results\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3313944-hewlett-packard-enterprise-beats-0_03-beats-revenue\" target=\"_blank\">Hewlett Packard Enterprise beats by $0.03, beats on revenue</a> (Nov. 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3313972\" data-linked=\"Hewlett Packard Enterprise -6% on Q4 beats, downside guidance, CEO change\" data-tweet=\"$HPE - Hewlett Packard Enterprise -6% on Q4 beats, downside guidance, CEO change https://seekingalpha.com/news/3313972-hewlett-packard-enterpriseminus-6-on-q4-beats-downside-guidance-ceo-change?source=tweet\" data-url=\"https://seekingalpha.com/news/3313972-hewlett-packard-enterpriseminus-6-on-q4-beats-downside-guidance-ceo-change\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313968\" data-ts=\"1511300313\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GES\" target=\"_blank\">GES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313968-guessminus-12-americas-retail-revenue-sinks-13-comp-salesminus-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Guess? -12% as Americas retail revenue sinks 13%, comp sales -10%</a></h4><ul>     <li>Guess (NYSE:<a href='https://seekingalpha.com/symbol/GES' title='Guess? Inc.'>GES</a>) <font color='red'>-12.2%</font> after-hours as <a href=\"https://seekingalpha.com/news/3313953-guess-eps-line-misses-revenue\" target=\"_blank\">Q3 earnings</a> match estimates but revenues fall short of expectations, and the company guides the midpoint of Q4 revenues well below consensus.</li>     <li>Retail revenue in the America remains weak, falling 13.4% Y/Y in U.S. dollars and 14.3% in constant  currency during Q3, and retail comp sales including e-commerce slid 10% in U.S. dollars and 11% in constant currency.</li>     <li>Results continue to be more promising in Europe and Asia, where Q3 revenues were up 19% and 17%, respectively, mainly driven by new store openings and positive comp sales.</li>     <li>Operating margin in the Americas Retail segment improved 240 bps to -2.5% in Q3 from -4.9% in the prior-year quarter, but margin for Europe fell 320 bps to 3.0% from 6.2% a year ago.</li>     <li>For Q4, GES sees EPS of  $0.48-$0.55 vs. $0.52 analyst consensus estimate and revenues +10%-12% to $647M-$761M vs. $753M consensus.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3313968\" data-linked=\"Guess? -12% as Americas retail revenue sinks 13%, comp sales -10%\" data-tweet=\"$GES - Guess? -12% as Americas retail revenue sinks 13%, comp sales -10% https://seekingalpha.com/news/3313968-guessminus-12-americas-retail-revenue-sinks-13-comp-salesminus-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3313968-guessminus-12-americas-retail-revenue-sinks-13-comp-salesminus-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313965\" data-ts=\"1511300093\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HPQ\" target=\"_blank\">HPQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313965-hpminus-5_2-after-q4-beats-in-line-guidance-and-flat-commercial-hardware\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HP -5.2% after Q4 beats, in-line guidance, and flat Commercial hardware</a></h4><ul><li>        HP (NYSE:<a href='https://seekingalpha.com/symbol/HPQ' title='HP Inc.'>HPQ</a>) shares are&nbsp;<font color='red'>down 5.2%</font>&nbsp;aftermarket following Q4 results that beat revenue estimates but came in-line on EPS. Slight growth in the tightened PC market was offset by stalled Commercial hardware growth.</li><li>                  Q1 guidance has EPS from $0.40 to $0.43 (consensus: $0.42) while FY18 guidance has EPs of $1.75 to $1.86 (consensus: $1.79).    </li><li>               Personal Systems segment revenue was up 14% on the year in constant currency with a 3.8% operating margin. The segment broke down into a 11% Commercial revenue growth and 18% Consumer growth. Total units rose 6% with Notebooks +8% and Desktops +2%.&nbsp;</li><li>                  Printer revenue was up 7% with a 16.6% operating margin. Total hardware was up 3% due to Consumer units since Commercial units were flat. Supplies revenue rose 11%. &nbsp;   </li><li>               Financials: cash from operating activities, $3.7B; FCF, $0.4B; accounts receivable, $4.4B; inventory, $5.8B; accounts payable, $13.3B; cash and equivalents, $1.1B.&nbsp; &nbsp;&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17009052-hp-inc-reports-fiscal-2017-full-year-fourth-quarter-results\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3313946-hp-eps-line-beats-revenue\" target=\"_blank\">HP EPS in-line, beats on revenue</a> (Nov. 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3313965\" data-linked=\"HP -5.2% after Q4 beats, in-line guidance, and flat Commercial hardware\" data-tweet=\"$HPQ - HP -5.2% after Q4 beats, in-line guidance, and flat Commercial hardware https://seekingalpha.com/news/3313965-hpminus-5_2-after-q4-beats-in-line-guidance-and-flat-commercial-hardware?source=tweet\" data-url=\"https://seekingalpha.com/news/3313965-hpminus-5_2-after-q4-beats-in-line-guidance-and-flat-commercial-hardware\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313963\" data-ts=\"1511300014\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GME\" target=\"_blank\">GME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313963-gamestopplus-3_4-another-gain-in-store-sales-drives-q3-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GameStop +3.4% as another gain in same-store sales drives Q3 beat</a></h4><ul>   <li>GameStop (NYSE:<a href='https://seekingalpha.com/symbol/GME' title='GameStop Corp.'>GME</a>) has settled into strong gains after hours, <font color='green'>up 3.4%</font>, after solid beats in its <a href=\"https://seekingalpha.com/news/3313947-gamestop-beats-0_11-beats-revenue\" target=\"_blank\">Q3 earnings</a> report driven by its third straight quarter of same-store sales growth.</li>    <li>Sales of the Nintendo Switch and collectibles were a bright spot along with new game software, mitigating a slowdown in used-game products.</li>    <li>&ldquo;As we enter the fourth quarter, we are encouraged by the initial customer response to Microsoft&rsquo;s Xbox One X, and believe that the holiday season results will be driven by new console hardware and collectibles,\" says interim CEO Dan DeMatteo.</li>    <li>EPS rose more than 10% as net earnings increased to $55.1M on an adjusted basis.</li>    <li>Overall sales were up 1.5% (flat in constant currency) to $1.99B; comparable store sales were up 1.9% (+0.6% in U.S., +4.6% internationally).</li>    <li>Net sales breakout: New videogame hardware, $309.5M (up 8.8%); New videogame software, $649.9M (up 5.4%); pre-owned and value videogame products, $458.5M (down 2.5%); Videogame accessories, $136.4M (down 12.6%); Digital, $37.2M (down 16.8%); Technology brands, $194.2M (down 10.2%); Collectibles, $138.4M (up 26.5%); Other, $64.5M (up 4.4%).</li>    <li>It's reiterated full-year guidance for EPS of $3.10-$3.40 (vs. $3.34 expected) and forecasts full-year comparable-store sales to rise in low to mid-single digits.</li>    <li><a href=\"http://investor.GameStop.com\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17009054-gamestop-reports-third-quarter-2017-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3313963\" data-linked=\"GameStop +3.4% as another gain in same-store sales drives Q3 beat\" data-tweet=\"$GME - GameStop +3.4% as another gain in same-store sales drives Q3 beat https://seekingalpha.com/news/3313963-gamestopplus-3_4-another-gain-in-store-sales-drives-q3-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3313963-gamestopplus-3_4-another-gain-in-store-sales-drives-q3-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313957\" data-ts=\"1511299231\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRYS\" target=\"_blank\">DRYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313957-dryships-slides-11-losses-triple-in-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DryShips slides 11% as losses triple in Q3</a></h4><ul>   <li>DryShips (NASDAQ:<a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a>) has tumbled after hours, <font color='red'>-10.8%</font>, after <a href=\"https://seekingalpha.com/news/3313945-dryships-reports-q3-results\" target=\"_blank\">q3 earnings</a> where voyage revenues rose but net loss tripled amid heavy financing losses.</li>    <li>Net loss attributable to common stockholders widened to $15.2M from a year-ago loss of $5.8M.</li>    <li>Depreciation rose to $5.5M from a year-ago $872,000. The company also saw higher interest and finance costs (of $3.6M) and took a $7.6M loss on private placement.</li>    <li>Average number of drybulk vessels rose to 21.8 from a year-ago 19.7, with total voyage days rising to 2,002 from 1,353, and fleet utilization rose to 100% from 75%.</li>    <li>Meanwhile, 4 new tanker vessels were online on average, with 368 voyage days and 100% utilization, and 1.2 gas carrier vessels, with 111 voyage days and also 100% utilization.</li>    <li>Time charter equivalent revenue by segment: Drybulk, $17.13M (up 268%); Tanker, $4.02M (new); Gas Carrier, $3.13M (new).</li>    <li>Cash and equivalents came to $25.9M. Book value of vessels, including advances, sits at $786.5M, about $7.54/share.</li>    <li><a href=\"https://seekingalpha.com/pr/17009038-dryships-inc-reports-financial-operating-results-third-quarter-2017\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3313957\" data-linked=\"DryShips slides 11% as losses triple in Q3\" data-tweet=\"$DRYS - DryShips slides 11% as losses triple in Q3 https://seekingalpha.com/news/3313957-dryships-slides-11-losses-triple-in-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3313957-dryships-slides-11-losses-triple-in-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>68&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313947\" data-ts=\"1511298495\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GME\" target=\"_blank\">GME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313947-gamestop-beats-0_11-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GameStop beats by $0.11, beats on revenue</a></h4><ul><li>GameStop (NYSE:<a href='https://seekingalpha.com/symbol/GME' title='GameStop Corp.'>GME</a>): Q3 EPS of $0.54 <font color='green'>beats by $0.11</font>.</li><li>Revenue of $1.99B (+1.5% Y/Y) <font color='green'>beats by $30M</font>.</li><li>Shares <font color='green'>+10%</font>.</li><li><a href='https://seekingalpha.com/pr/17009054-gamestop-reports-third-quarter-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3313947\" data-linked=\"GameStop beats by $0.11, beats on revenue\" data-tweet=\"$GME - GameStop beats by $0.11, beats on revenue https://seekingalpha.com/news/3313947-gamestop-beats-0_11-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3313947-gamestop-beats-0_11-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313945\" data-ts=\"1511298413\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRYS\" target=\"_blank\">DRYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313945-dryships-reports-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DryShips reports Q3 results</a></h4><ul><li>DryShips (NASDAQ:<a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a>): Q3 EPS of -$0.42</li><li>Revenue of $29.9M (+147.1% Y/Y)</li><li>Shares <font color='green'>+1.8%</font>.</li><li><a href='https://seekingalpha.com/pr/17009038-dryships-inc-reports-financial-operating-results-third-quarter-2017'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3313945\" data-linked=\"DryShips reports Q3 results\" data-tweet=\"$DRYS - DryShips reports Q3 results https://seekingalpha.com/news/3313945-dryships-reports-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3313945-dryships-reports-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313937\" data-ts=\"1511297392\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSNNF\" target=\"_blank\">SSNNF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313937-itc-recommends-tariffs-on-samsung-lg-to-benefit-whirlpool\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ITC recommends tariffs on Samsung, LG to benefit Whirlpool</a></h4><ul><li>        The U.S. International Trade Commission <a href=\"https://www.reuters.com/article/us-usa-trade-washers/u-s-commission-recommends-tariffs-to-curb-samsung-lg-washer-imports-idUSKBN1DL2CI\" target=\"_blank\">recommends tariffs</a> on Samsung (<a href='https://seekingalpha.com/symbol/SSNNF' title='Samsung Electronics Co., Ltd.'>OTC:SSNNF</a>, <a href='https://seekingalpha.com/symbol/SSNLF' title='Samsung Electronics Co., Ltd.'>OTC:SSNLF</a>) and LG to keep inexpensive washers from washing away Whirlpool (NYSE:<a href='https://seekingalpha.com/symbol/WHR' title='Whirlpool Corporation'>WHR</a>). &nbsp;</li><li>        The ITC says the graduated tariff rate should apply to large residential washers above 1.2M units for the next three years. The rate will start at 50% and drop to 40% by the third year.</li><li>               No consensus was reached on import tariffs on fewer than 1.2M units.&nbsp;</li><li>               President Trump should make the final decision in early 2018.&nbsp;</li><li>Whirlpool shares are&nbsp;<font color='green'>up 2.3%</font>.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3313937\" data-linked=\"ITC recommends tariffs on Samsung, LG to benefit Whirlpool\" data-tweet=\"$SSNNF $SSNNF $SSNLF - ITC recommends tariffs on Samsung, LG to benefit Whirlpool https://seekingalpha.com/news/3313937-itc-recommends-tariffs-on-samsung-lg-to-benefit-whirlpool?source=tweet\" data-url=\"https://seekingalpha.com/news/3313937-itc-recommends-tariffs-on-samsung-lg-to-benefit-whirlpool\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313934\" data-ts=\"1511297382\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DMPI\" target=\"_blank\">DMPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313934-delmars-lead-candidate-shows-positive-action-in-mid-stage-brain-cancer-study-shares-ahead-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DelMar&#39;s lead candidate shows positive action in mid-stage brain cancer study; shares ahead 9%</a></h4><ul><li>DelMar Pharmaceuticals (<a href='https://seekingalpha.com/symbol/DMPI' title='DelMar Pharmaceuticals, Inc.'>DMPI</a> <font color='green'>+8.9%</font>) is up on average volume on the heels of its <a href=\"https://seekingalpha.com/pr/17008965-delmar-presents-positive-interim-results-valminus-083-study-mgmt-unmethylated-recurrent-gbm\" target=\"_blank\">announcement </a>of preliminary results from a 48-subject Phase 2 clinical trial assessing lead candidate VAL-083 in patients with MGMT-unmethylated glioblastoma multiforme &#40;GBM&#41;. The data were presented at the Annual Meeting and Education Day of the Society for Neuro-Oncology in San Francisco.</li><li>15 patients have been enrolled to date. At the time of the interim analysis, 96% (14/15 = 93% so the origin of 96% is unclear) of enrollees were alive with 40% (n=6/15) showing stable disease. Median survival has not been reached.</li><li>On the safety front, VAL-083 was well-tolerated with the expected side effect of myelosuppression.</li><li>VAL-083 (dianhydrogalactitol) is a DNA-targeting agent that introduces interstrand DNA cross-links at the N7-position of guanine leading to DNA double-strand breaks and cancer cell death.</li></ul><div class=\"tiny-share-widget\" data-id=\"3313934\" data-linked=\"DelMar&#39;s lead candidate shows positive action in mid-stage brain cancer study; shares ahead 9%\" data-tweet=\"$DMPI - DelMar&#39;s lead candidate shows positive action in mid-stage brain cancer study; shares ahead 9% https://seekingalpha.com/news/3313934-delmars-lead-candidate-shows-positive-action-in-mid-stage-brain-cancer-study-shares-ahead-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3313934-delmars-lead-candidate-shows-positive-action-in-mid-stage-brain-cancer-study-shares-ahead-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313935\" data-ts=\"1511297165\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DE\" target=\"_blank\">DE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313935-deere-upgraded-baird-ahead-of-earnings-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deere upgraded at Baird ahead of earnings report</a></h4><ul>     <li>Deere (<a href='https://seekingalpha.com/symbol/DE' title='Deere & Company'>DE</a> <font color='green'>+1.7%</font>) rises to a 52-week high a day ahead of its quarterly earnings report, as Baird <a href=\"https://www.barrons.com/articles/tractors-gaining-traction-why-deere-demand-wont-get-plowed-under-1511280925\" target=\"_blank\">upgrades</a> shares to Outperform from Neutral with a $155 price target, raised from $140, as equipment dealers are seeing emerging replacement demand, which should provide a boost to sales.</li>     <li>Baird analyst Mig Dobre says he previously had downgraded DE on concerns that another record corn crop would pressure prices and push out or hold down the recovery in North American agricultural equipment demand, but equipment demand in October was very strong despite low crop prices.</li>     <li>Dobre also notes the 2018 Ag Equipment Intelligence dealer outlook survey showed the best growth outlook since 2012 with meaningful improvement vs. 2017.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3313935\" data-linked=\"Deere upgraded at Baird ahead of earnings report\" data-tweet=\"$DE - Deere upgraded at Baird ahead of earnings report https://seekingalpha.com/news/3313935-deere-upgraded-baird-ahead-of-earnings-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3313935-deere-upgraded-baird-ahead-of-earnings-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313932\" data-ts=\"1511295997\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JEC\" target=\"_blank\">JEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313932-jacobs-engineeringplus-9-after-strong-quarterly-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jacobs Engineering +9% after strong quarterly results</a></h4><ul>     <li>Jacobs Engineering (<a href='https://seekingalpha.com/symbol/JEC' title='Jacobs Engineering Group Inc.'>JEC</a> <font color='green'>+8.9%</font>) surges to a new 52-week high after easily beating <a href=\"https://seekingalpha.com/news/3313738-jacobs-engineering-beats-0_16-beats-revenue\" target=\"_blank\">FQ4 earnings</a> expectations, as results included sequential revenue growth, a significant increase in backlog and strong margin performance.</li>     <li>JEC's record-high $19.8B backlog at the end of the quarter came in well ahead of the $1.2B at the end of FQ3 and slightly more than $1B a year ago.\u200b</li>     <li>JEC also issues in-line earnings guidance for FY 2018, seeing EPS of $3.25-$3.60 vs. $3.44 analyst consensus estimate.</li><li>The company says it is on track to close the CH2M acquisition mid-December.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3313932\" data-linked=\"Jacobs Engineering +9% after strong quarterly results\" data-tweet=\"$JEC $J - Jacobs Engineering +9% after strong quarterly results https://seekingalpha.com/news/3313932-jacobs-engineeringplus-9-after-strong-quarterly-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3313932-jacobs-engineeringplus-9-after-strong-quarterly-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313931\" data-ts=\"1511295851\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRIP\" target=\"_blank\">TRIP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313931-ftc-reportedly-investigating-tripadvisors-deleted-reviews-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FTC reportedly investigating TripAdvisor&#39;s deleted reviews (update)</a></h4><ul><li>The Federal Trade Commission &#40;FTC&#41; is investigating TripAdvisor (NASDAQ:<a href='https://seekingalpha.com/symbol/TRIP' title='TripAdvisor Inc.'>TRIP</a>) for censoring user reviews containing reports of rape and sexual harassment.</li><li>The FTC sent a letter to Sen. Tammy Baldwin (D-WI) about the issue and said, &ldquo;The Commission has a strong interest in protecting consumer confidence in the online marketplace, including the robust online market for hotel and travel. When consumers are unable to post honest reviews about a business, it can harm other consumers whose abilities to make well-informed purchase decisions are hindered and harm businesses that work hard to earn positive reviews.&rdquo;</li><li>The FTC news comes from the Milwaukee Journal Sentinel, which originally broke the story that TripAdvisor was removing reviews with the assault claims as well as posts alleging harassment or discrimination.</li><li>TripAdvisor reacted to the backlash by instituting badges to flag hotels with negative reviews, but the badge expires in three months.</li><li>Sources: <a href=\"https://www.usatoday.com/story/news/nation-now/2017/11/21/tripadvisor-blocks-more-warnings/884750001/\" target=\"_blank\">Milwaukee Journal Sentinel</a> / <a href=\"https://www.theverge.com/2017/11/21/16686612/ftc-tripadvisor-investigation-forum-reports\" target=\"_blank\">The Verge</a></li><li>TripAdvisor shares are&nbsp;<font color='green'>up 7.7%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3308713-tripadvisor-q3-revenue-miss-hotel-sales-drop\" target=\"_blank\">TripAdvisor down after Q3 revenue miss, Hotel sales drop</a> (Nov. 6)</li><li>Update with TripAdvisor's statement to Seeking Alpha: \"We are not aware of an inquiry by the Federal Trade Commission nor have they contacted us.&nbsp; TripAdvisor is a global user-generated content platform that enables travelers to post positive and negative reviews and forum content about their experiences.&nbsp; We receive 290 pieces of content a minute and need to ensure that information posted on our site adheres to our content guidelines to ensure the integrity of these posts.&nbsp; We stand by our publishing guidelines and how they are applied.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3313931\" data-linked=\"FTC reportedly investigating TripAdvisor&#39;s deleted reviews (update)\" data-tweet=\"$TRIP - FTC reportedly investigating TripAdvisor&#39;s deleted reviews (update) https://seekingalpha.com/news/3313931-ftc-reportedly-investigating-tripadvisors-deleted-reviews-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3313931-ftc-reportedly-investigating-tripadvisors-deleted-reviews-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313929\" data-ts=\"1511294550\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRAY\" target=\"_blank\">CRAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313929-craig-hallum-upgrades-cray\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Craig Hallum upgrades Cray</a></h4><ul><li>        Craig Hallum <a href=\"https://www.streetinsider.com/Special+Reports/Pre-Open+Movers+1121%3A+%28CLSN%29+%28PANW%29+%28SNSS%29+Higher%3B+%28CYTK%29+%28QD%29+%28SIG%29+Lower+%28more...%29/13530735.html\" target=\"_blank\">upgrades</a> Cray (NASDAQ:<a href='https://seekingalpha.com/symbol/CRAY' title='Cray Inc'>CRAY</a>) from Hold to Buy with a $28 price target.</li><li>               Latest analyst recommendations (via <a href=\"https://markets.ft.com/data/equities/tearsheet/forecasts?s=CRAY:NSQ\" target=\"_blank\">FT</a>): 2 Buy, 1 Outperform, and 1 Hold.&nbsp;</li><li>               Cray shares are&nbsp;<font color='green'>up 11.1%</font>&nbsp;to $23.72.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3305852-cray-plus-3_4-percent-q3-beats-line-guidance\" target=\"_blank\">Cray +3.4% after Q3 beats, in-line guidance</a> (Oct. 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3313929\" data-linked=\"Craig Hallum upgrades Cray\" data-tweet=\"$CRAY - Craig Hallum upgrades Cray https://seekingalpha.com/news/3313929-craig-hallum-upgrades-cray?source=tweet\" data-url=\"https://seekingalpha.com/news/3313929-craig-hallum-upgrades-cray\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313927\" data-ts=\"1511294129\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313927-technology-top-gainers-losers-of-2-55-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2:55 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ATOM' title='Atomera Inc.'>ATOM</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/CMCM' title='Cheetah Mobile Inc.'>CMCM</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/FENG' title='Phoenix New Media Limited'>FENG</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/CUB' title='Cubic Corporation'>CUB</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/PTNR' title='Partner Communications Company Ltd.'>PTNR</a> <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/IPDN' title='Professional Diversity Network'>IPDN</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/BITA' title='Bitauto Holdings Limited'>BITA</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/NH' title='NantHealth'>NH</a> <font color='red'>-7%</font>. WPCS <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/VERI' title='Veritone'>VERI</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3313927\" data-linked=\"Technology - Top Gainers / Losers as of 2:55 pm\" data-tweet=\"$ATOM $CMCM $FENG - Technology - Top Gainers / Losers as of 2:55 pm https://seekingalpha.com/news/3313927-technology-top-gainers-losers-of-2-55-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3313927-technology-top-gainers-losers-of-2-55-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313925\" data-ts=\"1511293507\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WHR\" target=\"_blank\">WHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313925-whirlpoolplus-2_4-following-favorable-itc-decision-on-washer-imports\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Whirlpool +2.4% following favorable ITC decision on washer imports</a></h4><ul>     <li>Whirlpool (<a href='https://seekingalpha.com/symbol/WHR' title='Whirlpool Corporation'>WHR</a> <font color='green'>+2.4%</font>) spikes higher on news of a <a href=\"https://uk.reuters.com/article/usa-trade-washers/u-s-commission-calls-for-tariff-rate-quota-on-samsung-lg-washer-imports-idUKL1N1NR1E9\" target=\"_blank\">favorable decision on washer imports</a> by the U.S. International Trade Commission.</li>     <li>The ITC today recommended an additional 50% tariff on imported Samsung and LG brand washers after WHR urged the imposition of &ldquo;global safeguard&rdquo; limits to stop the South Korean companies from flooding the U.S. market with cheap machines.</li>     <li>Pres. Trump is expected to make a decision on the recommendation by early next year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3313925\" data-linked=\"Whirlpool +2.4% following favorable ITC decision on washer imports\" data-tweet=\"$WHR - Whirlpool +2.4% following favorable ITC decision on washer imports https://seekingalpha.com/news/3313925-whirlpoolplus-2_4-following-favorable-itc-decision-on-washer-imports?source=tweet\" data-url=\"https://seekingalpha.com/news/3313925-whirlpoolplus-2_4-following-favorable-itc-decision-on-washer-imports\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313923\" data-ts=\"1511292971\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CUB\" target=\"_blank\">CUB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313923-cubicplus-14_6-q4-beats-575m-contract\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cubic +14.6% Q4 beats, $575M contract</a></h4><ul><li>Cubic (NYSE:<a href='https://seekingalpha.com/symbol/CUB' title='Cubic Corporation'>CUB</a>) shares are&nbsp;<font color='green'>up 14.6%</font>&nbsp;after Q4 results that beat EPS and revenue estimates. FY18 guidance has revenue from $1.51B to $1.56B compared to the $1.56B consensus.</li><li>The company also <a href=\"https://seekingalpha.com/pr/17008253-cubic-selected-contract-boston-mbta-deliver-next-generation-fare-payment-system\" target=\"_blank\">announces receiving</a> a $575M contract from the Boston Massachusetts Bay Transportation Authority.</li><li>The 10-year contract involves designing, building, operating, and maintaining a fare payment system. The contract has two optional five-year extensions.</li><li>Analyst actions: Needham <a href=\"http://www.briefing.com/DisplayArticle/ArticlePopup.aspx?ArticleId=IN20171121090453CUB\" target=\"_blank\">raises</a> its Cubic price target from $56 to $62.</li><li>Canaccord Genuity <a href=\"http://www.briefing.com/DisplayArticle/ArticlePopup.aspx?ArticleId=IN20171121101715CUB\" target=\"_blank\">raises</a> its Cubic price target from $55 to $64.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3313640-cubic-beats-0_23-beats-revenue\" target=\"_blank\">Cubic beats by $0.23, beats on revenue</a> (Nov. 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3313923\" data-linked=\"Cubic +14.6% Q4 beats, $575M contract\" data-tweet=\"$CUB - Cubic +14.6% Q4 beats, $575M contract https://seekingalpha.com/news/3313923-cubicplus-14_6-q4-beats-575m-contract?source=tweet\" data-url=\"https://seekingalpha.com/news/3313923-cubicplus-14_6-q4-beats-575m-contract\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313920\" data-ts=\"1511292002\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSUR\" target=\"_blank\">OSUR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313920-orasure-up-11-on-143m-oragene-dx-supply-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OraSure up 11% on $143M Oragene Dx supply deal</a></h4><ul><li>OraSure Technologies (<a href='https://seekingalpha.com/symbol/OSUR' title='OraSure Technologies, Inc.'>OSUR</a> <font color='green'>+11.3%</font>) jumps on more than double normal volume in response to its <a href=\"https://seekingalpha.com/filing/3774311\" target=\"_blank\">disclosure </a>that subsidiary DNAG Genotek closed a $143M deal to supply its Oragene Dx devices to a \"leading consumer genomics customer.\"</li><li>Oragene Dx is an FDA-cleared saliva DNA collection and stabilization device that enables ambient temperature transportation.</li></ul><div class=\"tiny-share-widget\" data-id=\"3313920\" data-linked=\"OraSure up 11% on $143M Oragene Dx supply deal\" data-tweet=\"$OSUR - OraSure up 11% on $143M Oragene Dx supply deal https://seekingalpha.com/news/3313920-orasure-up-11-on-143m-oragene-dx-supply-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3313920-orasure-up-11-on-143m-oragene-dx-supply-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313915\" data-ts=\"1511291080\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313915-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/AXU' title='Alexco Resource Corporation'>AXU</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/RYAM' title='Rayonier Advanced Materials'>RYAM</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/MXC' title='Mexco Energy Corporation'>MXC</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/MTL' title='Mechel OAO'>MTL</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/AGI' title='Alamos Gold Inc'>AGI</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/WLB' title='Westmoreland Coal Co'>WLB</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/EPE' title='EP Energy Corporation'>EPE</a> <font color='red'>-20%</font>. SGY <font color='red'>-14%</font>. BBG <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/SNMX' title='Senomyx, Inc.'>SNMX</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3313915\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$AXU $RYAM $MXC - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3313915-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3313915-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313912\" data-ts=\"1511290078\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGI\" target=\"_blank\">AGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313912-alamos-gold-receives-final-court-approval-to-acquire-richmont-mines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alamos Gold receives final court approval to acquire Richmont Mines</a></h4><ul>     <li>Alamos Gold (<a href='https://seekingalpha.com/symbol/AGI' title='Alamos Gold Inc'>AGI</a> <font color='green'>+6.4%</font>) have been granted final court approval from the Quebec Superior Court of the plan of arrangement whereby Alamos will acquire all of the issued and outstanding shares of Richmont.</li>     <li>The Transaction is expected to close on Nov. 23, 2017, subject to applicable regulatory approvals and the satisfaction of other customary conditions.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3294594-alamos-gold-acquires-richmont-mines\" target=\"_blank\">Alamos Gold acquires Richmont Mines</a> (Sept. 11)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3313912\" data-linked=\"Alamos Gold receives final court approval to acquire Richmont Mines\" data-tweet=\"$AGI $RIC - Alamos Gold receives final court approval to acquire Richmont Mines https://seekingalpha.com/news/3313912-alamos-gold-receives-final-court-approval-to-acquire-richmont-mines?source=tweet\" data-url=\"https://seekingalpha.com/news/3313912-alamos-gold-receives-final-court-approval-to-acquire-richmont-mines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313907\" data-ts=\"1511289073\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNGX\" target=\"_blank\">SNGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313907-soligenix-registers-sale-of-982k-common-shares-stockholders-shares-down-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Soligenix registers sale of 982K common shares by stockholders; shares down 1%</a></h4><ul><li>Soligenix (<a href='https://seekingalpha.com/symbol/SNGX' title='Soligenix, Inc.'>SNGX</a> <font color='red'>-0.9%</font>) files an <a href=\"https://www.sec.gov/Archives/edgar/data/812796/000121390017012407/fs12017_soligenixinc.htm\" target=\"_blank\">S-1</a> to register the sale of 982K shares of common stock by existing shareholders.</li></ul><div class=\"tiny-share-widget\" data-id=\"3313907\" data-linked=\"Soligenix registers sale of 982K common shares by stockholders; shares down 1%\" data-tweet=\"$SNGX - Soligenix registers sale of 982K common shares by stockholders; shares down 1% https://seekingalpha.com/news/3313907-soligenix-registers-sale-of-982k-common-shares-stockholders-shares-down-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3313907-soligenix-registers-sale-of-982k-common-shares-stockholders-shares-down-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313906\" data-ts=\"1511288824\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONTX\" target=\"_blank\">ONTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313906-onconova-registers-84_5m-mixed-shelf-offering-shares-down-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Onconova registers $84.5M mixed shelf offering; shares down 1%</a></h4><ul><li>Onconova Therapeutics (<a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics'>ONTX</a> <font color='red'>-0.7%</font>) files a <a href=\"https://www.sec.gov/Archives/edgar/data/1130598/000110465917069666/a17-27395_1s3.htm\" target=\"_blank\">prospectus </a>(S-3) for an ~$84.5M mixed shelf offering. Net proceeds will fund clinical trials, R&amp;D and general corporate purposes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3313906\" data-linked=\"Onconova registers $84.5M mixed shelf offering; shares down 1%\" data-tweet=\"$ONTX - Onconova registers $84.5M mixed shelf offering; shares down 1% https://seekingalpha.com/news/3313906-onconova-registers-84_5m-mixed-shelf-offering-shares-down-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3313906-onconova-registers-84_5m-mixed-shelf-offering-shares-down-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313904\" data-ts=\"1511287814\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDXG\" target=\"_blank\">MDXG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313904-mimedx-down-5-on-new-viceroy-report-of-misconduct\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MiMedx down 5% on new Viceroy report of misconduct</a></h4><ul><li>Embattled MiMedx (<a href='https://seekingalpha.com/symbol/MDXG' title='MiMedx Group Inc.'>OTC:MDXG</a> <font color='red'>-4.5%</font>) slumps on lower-than-normal volume on the heels of a November <a href=\"https://viceroyresearch.org/2017/11/\" target=\"_blank\">report </a>by Viceroy Research reiterating its accusations of corporate misconduct related sales to the Veterans Administration.</li><li>It cites a series of emails between the company and the VA related to the arrangement of consignment inventory which it says was contrary to VA policy at that time and corroborates allegations of channel stuffing.</li><li>Also cited are company emails to former employees related to settlements that were contingent on retracting statements to regulatory authorities that it claims violate federal law and emails from company employees to doctors detailing how to manipulate reimbursement codes for financial gain, a scheme called \"up-coding.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3313904\" data-linked=\"MiMedx down 5% on new Viceroy report of misconduct\" data-tweet=\"$MDXG - MiMedx down 5% on new Viceroy report of misconduct https://seekingalpha.com/news/3313904-mimedx-down-5-on-new-viceroy-report-of-misconduct?source=tweet\" data-url=\"https://seekingalpha.com/news/3313904-mimedx-down-5-on-new-viceroy-report-of-misconduct\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313898\" data-ts=\"1511287237\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313898-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/FANH' title='Fanhua Inc.'>FANH</a> <font color='green'>+8%</font>.<a href='https://seekingalpha.com/symbol/MHLD' title='Maiden Hldgs Ltd'>MHLD</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/OPHC' title='OptimumBank Holdings, Inc.'>OPHC</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/QD' title='Qudian, Inc.'>QD</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/LEJU' title='Leju Holdings Limited'>LEJU</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/CARV' title='Carver Bancorp, Inc.'>CARV</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3313898\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$GROW $FANH $MHLD - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3313898-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3313898-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313897\" data-ts=\"1511286269\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTN\" target=\"_blank\">PTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313897-palatin-establishes-bremelanotide-distribution-in-korea-shares-ahead-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Palatin establishes bremelanotide distribution in Korea; shares ahead 7%</a></h4><ul><li>Palatin Technologies (<a href='https://seekingalpha.com/symbol/PTN' title='Palatin Technologies, Inc'>PTN</a> <font color='green'>+7.1%</font>) inks a collaboration and license <a href=\"https://seekingalpha.com/pr/17008199-palatin-technologies-announces-signing-licensing-agreement-kwangdong-pharmaceutical-republic\" target=\"_blank\">agreement </a>with Kwangdong Pharmaceutical Co., Ltd. for the exclusive rights to develop and commercialize bremelanotide for female sexual dysfunction indications in Korea.</li><li>Under the terms of the agreement, Palatin will receive $500K upfront, $3M triggered by the first commercial sale, up to $37.5M in sales-related milestones and mid-single-digit-to-low-double-digit royalties on net sales.</li><li><a href=\"http://www.palatin.com/products/bremelanotide.asp\" target=\"_blank\">Bremelanotide&nbsp;</a>is a synthetic peptide analog of the naturally occurring hormone&nbsp;<a href=\"https://en.wikipedia.org/wiki/Alpha-Melanocyte-stimulating_hormone\" target=\"_blank\">alpha-MSH</a>, a melanocortin agonist. The&nbsp;<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12556347\" target=\"_blank\">melanocortin system</a>&nbsp;plays a key role in sexual function as well as pigmentation, inflammation and energy homeostasis.</li><li>A U.S. marketing application will be filed in Q1 2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3313897\" data-linked=\"Palatin establishes bremelanotide distribution in Korea; shares ahead 7%\" data-tweet=\"$PTN - Palatin establishes bremelanotide distribution in Korea; shares ahead 7% https://seekingalpha.com/news/3313897-palatin-establishes-bremelanotide-distribution-in-korea-shares-ahead-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3313897-palatin-establishes-bremelanotide-distribution-in-korea-shares-ahead-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313896\" data-ts=\"1511286019\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313896-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CLSN' title='Celsion Corporation'>CLSN</a> <font color='green'>+47%</font>. <a href='https://seekingalpha.com/symbol/OMNT' title='Ominto, Inc.'>OTCPK:OMNT</a> <font color='green'>+33%</font>. <a href='https://seekingalpha.com/symbol/ACHV' title='Achieve Life Sciences, Inc.'>ACHV</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/ATOM' title='Atomera Inc.'>ATOM</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/CADC' title='China Advanced Construction Materials Group, Inc.'>CADC</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/EKSO' title='Ekso Bionics Holdings, Inc.'>EKSO</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/CMCM' title='Cheetah Mobile Inc.'>CMCM</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/RELV' title='Reliv&#39; International, Inc.'>RELV</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/CUB' title='Cubic Corporation'>CUB</a> <font color='green'>+15%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SIG' title='Signet Jewelers Limited'>SIG</a> <font color='red'>-28%</font>. <a href='https://seekingalpha.com/symbol/CYTK' title='Cytokinetics, Incorporated'>CYTK</a> <font color='red'>-26%</font>. <a href='https://seekingalpha.com/symbol/ACST' title='Acasti Pharma, Inc.'>ACST</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/OPHC' title='OptimumBank Holdings, Inc.'>OPHC</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/TEDU' title='Tarena International, Inc.'>TEDU</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/WLB' title='Westmoreland Coal Co'>WLB</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/DSW' title='DSW Inc.'>DSW</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/MRDN' title='Meridian Waste Solutions, Inc.'>OTCQB:MRDN</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/DCIX' title='Diana Containerships Inc.'>DCIX</a> <font color='red'>-11%</font>. SGY <font color='red'>-11%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3313896\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$CLSN $OMNT $ACHV - Midday Gainers / Losers https://seekingalpha.com/news/3313896-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3313896-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313893\" data-ts=\"1511284930\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARQL\" target=\"_blank\">ARQL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313893-arqule-launches-registration-trial-for-derazantinib-in-second-line-icca\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ArQule launches registration trial for derazantinib in second-line iCCA</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17008138-arqule-announces-dosing-registrational-trial-fgfr-inhibitor-derazantinib-treatment\" target=\"_blank\">Dosing is underway</a> in an open-label, single-arm study assessing ArQule's (<a href='https://seekingalpha.com/symbol/ARQL' title='ArQule, Inc.'>ARQL</a> <font color='red'>-4.6%</font>) derazantinib (ARQ 087) for the treatment of FGFR2 fusion-driven intrahepatic cholangiocarcinoma (iCCA). The primary endpoint is objective response rate. According to ClinicalTrials.gov, the estimated primary completion date is September 2020.</li><li>The company intends to use the data from the <a href=\"https://clinicaltrials.gov/ct2/show/NCT03230318?term=arq+087&amp;rank=2\" target=\"_blank\">100-subject Phase 3 trial</a> to support a marketing application seeking accelerated approval. An interim analysis will be performed after the first 40 participants have been evaluated for response. In an earlier Phase 1/2 study, the durable response rate was 21%.</li><li>CCA is also known as bile duct cancer. Intrahepatic CCA occurs within the liver. Other forms of CCA can occur in bile ducts outside of the liver.</li><li>Derazantinib is a multi-kinase inhibitor designed to selectively inhibit the fibroblast growth factor receptor &#40;FGFR&#41; family. The FGFR pathway is disrupted in cancer, providing a range of therapeutic targets.</li><li>Shares are down on what appears to be profit-taking after its ~40% run-up this month.</li></ul><div class=\"tiny-share-widget\" data-id=\"3313893\" data-linked=\"ArQule launches registration trial for derazantinib in second-line iCCA\" data-tweet=\"$ARQL - ArQule launches registration trial for derazantinib in second-line iCCA https://seekingalpha.com/news/3313893-arqule-launches-registration-trial-for-derazantinib-in-second-line-icca?source=tweet\" data-url=\"https://seekingalpha.com/news/3313893-arqule-launches-registration-trial-for-derazantinib-in-second-line-icca\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313892\" data-ts=\"1511284377\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CREG\" target=\"_blank\">CREG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313892-china-recycling-energyplus-7-on-plan-to-transform-energy-storage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Recycling Energy +7% on plan to transform into energy storage</a></h4><ul>     <li>China Recycling Energy (<a href='https://seekingalpha.com/symbol/CREG' title='China Recycling Energy Corporation'>CREG</a> <font color='green'>+7.4%</font>) is higher after announcing plans to <a href=\"https://seekingalpha.com/pr/17008585-china-recycling-energy-announces-intention-strategic-transformation-energy-storage-areas\" target=\"_blank\">transform itself</a> into an \"energy storage integrated solution provider.\"</li>     <li>CREG cites results from Yano Economy Research Institute which show the energy storage market enjoying rapid growth and the size of the market in 2017 and 2020 will reach 1.196 GW and 3.307 GW, respectively.</li>     <li>CREEG predicts China&rsquo;s energy storage market will reach 66.8 GW by 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3313892\" data-linked=\"China Recycling Energy +7% on plan to transform into energy storage\" data-tweet=\"$CREG - China Recycling Energy +7% on plan to transform into energy storage https://seekingalpha.com/news/3313892-china-recycling-energyplus-7-on-plan-to-transform-energy-storage?source=tweet\" data-url=\"https://seekingalpha.com/news/3313892-china-recycling-energyplus-7-on-plan-to-transform-energy-storage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313890\" data-ts=\"1511284088\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLMN\" target=\"_blank\">BLMN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313890-bloomin-brands-will-consider-perspectives-of-jana\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomin&#39; Brands will &#39;consider perspectives&#39; of Jana</a></h4><ul><li>Confirming Jana Partners' 13D filing from yesterday, Bloomin' Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/BLMN' title='Bloomin&#39; Brands'>BLMN</a>) says it \"appreciates the views of its stockholders and will consider the perspectives reflected\" in the filing.</li><li>Jana plans to push for strategic alternatives, including exploration of a sale.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17008785-bloomin-brands-confirms-13d-filing\" target=\"_blank\">Press Release</a></li><li>Shares are&nbsp;<font color='red'>down 1.2%</font>&nbsp;today after yesterday's double-digit spike.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3313598-bloomin-brands-spikes-jana-partners-applies-pressure\" target=\"_blank\">Bloomin' Brands spikes after Jana Partners applies pressure</a> (Nov. 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3313890\" data-linked=\"Bloomin&#39; Brands will &#39;consider perspectives&#39; of Jana\" data-tweet=\"$BLMN - Bloomin&#39; Brands will &#39;consider perspectives&#39; of Jana https://seekingalpha.com/news/3313890-bloomin-brands-will-consider-perspectives-of-jana?source=tweet\" data-url=\"https://seekingalpha.com/news/3313890-bloomin-brands-will-consider-perspectives-of-jana\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313888\" data-ts=\"1511283649\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313888-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/RELV' title='Reliv&#39; International, Inc.'>RELV</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/UQM' title='UQM Technologies, Inc'>UQM</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/MOV' title='Movado Group, Inc.'>MOV</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/TOUR' title='Tuniu Corporation'>TOUR</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/KBSF' title='KBS Fashion Group Limited'>KBSF</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CPB' title='Campbell Soup Company'>CPB</a> <font color='red'>-8%</font>. LTEA <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3313888\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$RELV $UQM $MOV - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3313888-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3313888-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313871\" data-ts=\"1511282643\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELG\" target=\"_blank\">CELG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313871-celgene-up-2-after-be-generic-competitor-misses-deadline-to-file-for-revlimid-patent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celgene up 2% after would-be generic competitor misses deadline to file for Revlimid patent challenge</a></h4><ul><li>Celgene (<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color='green'>+2%</font>) heads north, albeit on lower-than-normal volume, after expected generic competitor Dr. Reddy's Laboratories (<a href='https://seekingalpha.com/symbol/RDY' title='Dr. Reddy&#39;s Laboratories Limited'>RDY</a> <font color='green'>+4.1%</font>) failed to file for inter partes review of patents covering top seller Revlimid (lenalidomide). Analysts had expected the entry of generics in 2020 but now it appears that the company has a longer runway before it faces the threat.</li><li>Dr. Reddy's is up in response to the <a href=\"http://www.moneycontrol.com/news/business/stocks-business/dr-reddys-gains-9-on-eir-from-usfda-for-vizag-facility-but-inspection-still-on-2443259.html\" target=\"_blank\">news </a>that the FDA has issued its report &#40;EIR&#41; detailing its findings from an inspection of its Vizag facility in Duvvada, Visakhapatnam. The company intends to request a reinspection of the site in 2018. The FDA <a href=\"http://www.thehindubusinessline.com/companies/usfda-to-reaudit-dr-reddys-three-plants/article9475990.ece\" target=\"_blank\">issued </a>a Warning Letter to the company in November 2015 related to GMP violations there (as well as two other facilities).</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3313871\" data-linked=\"Celgene up 2% after would-be generic competitor misses deadline to file for Revlimid patent challenge\" data-tweet=\"$CELG $CELG $RDY - Celgene up 2% after would-be generic competitor misses deadline to file for Revlimid patent challenge https://seekingalpha.com/news/3313871-celgene-up-2-after-be-generic-competitor-misses-deadline-to-file-for-revlimid-patent?source=tweet\" data-url=\"https://seekingalpha.com/news/3313871-celgene-up-2-after-be-generic-competitor-misses-deadline-to-file-for-revlimid-patent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313877\" data-ts=\"1511282573\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313877-mexico-on-move-on-nafta-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mexico on the move on Nafta chatter</a></h4><ul><li>Negotiators are near deals on telecom, energy, and digital commerce, according to Juan Pablo Castanon, chief of Mexico's version of the Chamber of Commerce.</li><li>The peso is&nbsp;<font color='green'>up more than 1%</font>&nbsp;vs. the dollar, and the iShares MSCI Mexico ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/EWW' title='iShares MSCI Mexico Capped ETF'>EWW</a>) is&nbsp;<font color='green'>higher by 2%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EWW' title='iShares MSCI Mexico Capped ETF'>EWW</a>, <a href='https://seekingalpha.com/symbol/MXF' title='Mexico Fund'>MXF</a>, <a href='https://seekingalpha.com/symbol/MXE' title='Mexico Equity&Income Fund'>MXE</a>, <a href='https://seekingalpha.com/symbol/DBMX' title='Deutsche X-trackers MSCI Mexico Hedged Equity ETF'>DBMX</a>, <a href='https://seekingalpha.com/symbol/HEWW' title='iShares Currency Hedged MSCI Mexico ETF'>HEWW</a>, <a href='https://seekingalpha.com/symbol/MEXX' title='Direxion Daily MSCI Mexico Bull 3X ETF'>MEXX</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3313877\" data-linked=\"Mexico on the move on Nafta chatter\" data-tweet=\"$EWW $MXF $MXE - Mexico on the move on Nafta chatter https://seekingalpha.com/news/3313877-mexico-on-move-on-nafta-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/3313877-mexico-on-move-on-nafta-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313868\" data-ts=\"1511281346\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313868-nasdaqs-1-advance-leads-averages-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nasdaq&#39;s 1% advance leads averages higher</a></h4><ul><li>There's green all over the screen, with Apple, Microsoft, Facebook, and Google leading the Nasdaq&nbsp;<font color='green'>higher by 1%</font>.</li><li>Healthcare is also an area of strength, with Medtronic&nbsp;<font color='green'>up 5.4%</font>&nbsp;following an earnings beat, and Celgene&nbsp;<font color='green'>up more than 2%</font>&nbsp;after Dr. Reddy's failed to file for a patent procedure for a generic Revlimid.</li><li>The S&amp;P 500 is<font color='green'> up 0.6%</font>, topping 2,600 for the first time (before pulling back a hair). The Dow is&nbsp;<font color='green'>ahead 0.7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3313868\" data-linked=\"Nasdaq&#39;s 1% advance leads averages higher\" data-tweet=\"Nasdaq&#39;s 1% advance leads averages higher https://seekingalpha.com/news/3313868-nasdaqs-1-advance-leads-averages-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3313868-nasdaqs-1-advance-leads-averages-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313865\" data-ts=\"1511281087\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIA\" target=\"_blank\">VIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313865-viacom-launches-tender-offer-for-up-to-1b-in-debt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Viacom launches tender offer for up to $1B in debt</a></h4><ul>   <li>Viacom (<a href='https://seekingalpha.com/symbol/VIA' title='Viacom Inc.'>VIA</a> <font color='green'>+1.2%</font>, <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a> <font color='green'>+1.7%</font>) has <a href=\"https://seekingalpha.com/pr/17008268-viacom-announces-cash-tender-offers-1_0-billion-aggregate-purchase-price-certain-outstanding\" target=\"_blank\">launched cash tenders</a> for up to $1B of certain of its debt securities.</li>    <li>Among the top priorities for acceptance in the tender are $104M outstanding principal in 4.5% senior debentures due 2042; $37.3M in 4.875% senior debentures due 2043; $591.8M in 4.85% senior debentures due 2034; and $594M in 3.45% senior notes due 2026.</li>    <li>The offers are set to expire in the evening of Dec. 19; withdrawal deadline is Dec. 5 and valid tenders by that deadline will get an early tender premium of $30 per $1,000 principal.</li>    <li>Viacom's total debt at last report was $11.12B, with $1.39B in cash.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3313865\" data-linked=\"Viacom launches tender offer for up to $1B in debt\" data-tweet=\"$VIA $VIA $VIAB - Viacom launches tender offer for up to $1B in debt https://seekingalpha.com/news/3313865-viacom-launches-tender-offer-for-up-to-1b-in-debt?source=tweet\" data-url=\"https://seekingalpha.com/news/3313865-viacom-launches-tender-offer-for-up-to-1b-in-debt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313864\" data-ts=\"1511280789\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313864-cowen-analyst-says-amazon-should-buy-rite-aid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cowen analyst says Amazon should buy Rite Aid</a></h4><ul><li>        A Cowen analyst says Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) should <a href=\"https://www.cnbc.com/2017/11/21/cowen-an-amazon-rite-aid-deal-makes-sense.html\" target=\"_blank\">acquire</a> Rite Aid (NYSE:<a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a>) for faster access to the legal side of the pharmacy business.</li><li>               Analyst John Blackledge says the Rite Aid buy would bring along pharmacy licenses and infrastructure that could benefit the company if moving to open pharmacies in Whole Foods or to offer medication through the Prime services.&nbsp;</li><li>               Blackledge says the firm&rsquo;s research shows that 67% of Amazon Prime members would buy prescription drugs through the platform.&nbsp;</li><li>               Blackledge estimates Amazon&rsquo;s U.S. retail pharmacy business could generate $20B in 2019 with the Rite Aid deal.&nbsp;&nbsp;</li><li>Amazon shares are&nbsp;<font color='green'>up 1.02%</font>.</li><li>Rite Aid shares are&nbsp;<font color='green'>up 3.53%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3313864\" data-linked=\"Cowen analyst says Amazon should buy Rite Aid\" data-tweet=\"$AMZN $AMZN $RAD - Cowen analyst says Amazon should buy Rite Aid https://seekingalpha.com/news/3313864-cowen-analyst-says-amazon-should-buy-rite-aid?source=tweet\" data-url=\"https://seekingalpha.com/news/3313864-cowen-analyst-says-amazon-should-buy-rite-aid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>212&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313862\" data-ts=\"1511280580\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSRO\" target=\"_blank\">TSRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313862-tesaro-secures-500m-credit-line-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TESARO secures $500M credit line; shares up 3%</a></h4><ul><li>TESARO (<a href='https://seekingalpha.com/symbol/TSRO' title='Tesaro'>TSRO</a> <font color='green'>+2.7%</font>) inks term loan <a href=\"https://seekingalpha.com/pr/17008308-tesaro-secures-500-million-non-dilutive-term-loan-financing\" target=\"_blank\">agreements </a>with two investment funds establishing up to $500M in borrowing capacity. The company intends to draw $300M by early December and has the option to draw up to an additional $200M by December 20, 2018.</li><li>The funding will support the commercialization of ZEJULA (niraparib) in ovarian cancer, the development of new indications and the advancement of pipeline candidates.</li></ul><div class=\"tiny-share-widget\" data-id=\"3313862\" data-linked=\"TESARO secures $500M credit line; shares up 3%\" data-tweet=\"$TSRO - TESARO secures $500M credit line; shares up 3% https://seekingalpha.com/news/3313862-tesaro-secures-500m-credit-line-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3313862-tesaro-secures-500m-credit-line-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313830\" data-ts=\"1511280033\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313830-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CLSN' title='Celsion Corporation'>CLSN</a> <font color='green'>+59%</font>. <a href='https://seekingalpha.com/symbol/ACHV' title='Achieve Life Sciences, Inc.'>ACHV</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/CHFS' title='CHF Solutions, Inc.'>CHFS</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/CASI' title='CASI Pharmaceuticals'>CASI</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/EKSO' title='Ekso Bionics Holdings, Inc.'>EKSO</a> <font color='green'>+16%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CYTK' title='Cytokinetics, Incorporated'>CYTK</a> <font color='red'>-30%</font>. <a href='https://seekingalpha.com/symbol/ACST' title='Acasti Pharma, Inc.'>ACST</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/ENTA' title='Enanta Pharmaceuticals, Inc.'>ENTA</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/OASM' title='Oasmia Pharmaceutical'>OASM</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/GKOS' title='Glaukos'>GKOS</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3313830\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$CLSN $ACHV $CHFS - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3313830-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3313830-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313859\" data-ts=\"1511279913\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCSA\" target=\"_blank\">CMCSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313859-comcast-up-buckingham-initiates-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comcast up as Buckingham initiates at Buy</a></h4><ul>   <li>Comcast (NASDAQ:<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>) is <font color='green'>up 1.7%</font> after Buckingham initiated coverage with a Buy rating.</li>    <li>The firm set a $48 price target, implying more than 31% upside from today's higher price.</li>    <li>Meanwhile, the stock was removed from the US1 list at BofA Merrill Lynch.</li>    <li>Shares are <font color='green'>up 5.4%</font> in 2017.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3313859\" data-linked=\"Comcast up as Buckingham initiates at Buy\" data-tweet=\"$CMCSA - Comcast up as Buckingham initiates at Buy https://seekingalpha.com/news/3313859-comcast-up-buckingham-initiates-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3313859-comcast-up-buckingham-initiates-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313856\" data-ts=\"1511279702\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIG\" target=\"_blank\">SIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313856-signet-plunges-27-after-earnings-cut-in-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Signet plunges 27% after earnings, cut in guidance</a></h4><ul><li>CEO Virginia Drosos takes note of a \"challenging\" Q3, with the hurricanes and unexpected disruptions during the credit services transition adding to what was already expected to be a sequential slowdown in same-store sales (they fell 5%, with the weather and credit items having a 120 basis points negative impact).</li><li>The Q4 outlook is cut, with same-store sales now seen as down low- to mid-single digits.</li><li>Fiscal 2018 EPS guidance is cut to $6.10-$6.50 from $7.16-$7.56, Same-store sales are now seen at down mid single-digits vs. previous down low- to mid-single digits.</li><li><a href='https://seekingalpha.com/symbol/SIG' title='Signet Jewelers Limited'>SIG</a>&nbsp;<font color='red'>-27%</font>, <a href='https://seekingalpha.com/symbol/TIF' title='Tiffany & Co.'>TIF</a>&nbsp;<font color='red'>-1.1%</font></li><li>Previously: <a href=\"https://seekingalpha.com/news/3313751-signet-beats-0_05-misses-revenue\" target=\"_blank\">Signet beats by $0.05, misses on revenue</a> (Nov. 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3313856\" data-linked=\"Signet plunges 27% after earnings, cut in guidance\" data-tweet=\"$SIG $SIG $TIF - Signet plunges 27% after earnings, cut in guidance https://seekingalpha.com/news/3313856-signet-plunges-27-after-earnings-cut-in-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3313856-signet-plunges-27-after-earnings-cut-in-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313854\" data-ts=\"1511279689\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSY\" target=\"_blank\">SSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313854-sunlink-health-initiates-tender-offer-for-17-of-outstanding-stock-shares-up-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunLink Health initiates tender offer for 17% of outstanding stock; shares up 15%</a></h4><ul><li>SunLink Health Systems (<a href='https://seekingalpha.com/symbol/SSY' title='SunLink Health Systems, Inc'>SSY</a> <font color='green'>+15.4%</font>) <a href=\"https://seekingalpha.com/pr/17008409-sunlink-health-systems-inc-announces-intention-commence-tender-offer-repurchase-1562-500\" target=\"_blank\">announces </a>plans for a tender offer by next week to purchase up to 1,562,500 shares of its common stock at $1.60 per share representing ~%17 of its outstanding stock. The action will be funded with cash on hand.</li></ul><div class=\"tiny-share-widget\" data-id=\"3313854\" data-linked=\"SunLink Health initiates tender offer for 17% of outstanding stock; shares up 15%\" data-tweet=\"$SSY - SunLink Health initiates tender offer for 17% of outstanding stock; shares up 15% https://seekingalpha.com/news/3313854-sunlink-health-initiates-tender-offer-for-17-of-outstanding-stock-shares-up-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3313854-sunlink-health-initiates-tender-offer-for-17-of-outstanding-stock-shares-up-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313853\" data-ts=\"1511279235\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRX\" target=\"_blank\">CPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313853-catalyst-pharma-launches-mid-stage-study-of-firdapse-in-sma-type-3-shares-ahead-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catalyst Pharma launches mid-stage study of Firdapse in SMA Type 3; shares ahead 5%</a></h4><ul><li>Catalyst Pharmaceuticals (<a href='https://seekingalpha.com/symbol/CPRX' title='Catalyst Pharmaceuticals, Inc.'>CPRX</a> <font color='green'>+4.9%</font>) <a href=\"https://seekingalpha.com/pr/17008322-catalyst-pharmaceuticals-announces-phase-2-study-firdapse-ambulatory-patients-spinal-muscular\" target=\"_blank\">initiates </a>a proof-of-concept Phase 2 clinical trial evaluating Firdapse (amifampridine phosphate) for the symptomatic treatment of patients with Spinal Muscular Atrophy &#40;SMA&#41; Type 3.</li><li>Topline results from the 12-subject study should be available in H1 2019.</li><li>The company acquired <a href=\"http://www.catalystpharma.com/firdapse.shtml\" target=\"_blank\">North American rights</a> from original developer BioMarin Pharmaceutical in October 2012.</li></ul><div class=\"tiny-share-widget\" data-id=\"3313853\" data-linked=\"Catalyst Pharma launches mid-stage study of Firdapse in SMA Type 3; shares ahead 5%\" data-tweet=\"$CPRX - Catalyst Pharma launches mid-stage study of Firdapse in SMA Type 3; shares ahead 5% https://seekingalpha.com/news/3313853-catalyst-pharma-launches-mid-stage-study-of-firdapse-in-sma-type-3-shares-ahead-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3313853-catalyst-pharma-launches-mid-stage-study-of-firdapse-in-sma-type-3-shares-ahead-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313851\" data-ts=\"1511278998\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313851-bloomberg-apple-plans-to-ship-4m-homepod-units-next-year\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Apple plans to ship 4M HomePod units next year</a></h4><ul><li>Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) expects to ship 4M HomePods next year, according to <a href=\"https://www.bloomberg.com/news/articles/2017-11-21/why-apple-s-homepod-is-three-years-behind-amazon-s-echo\" target=\"_blank\">Bloomberg</a> sources.</li><li>The company recently bumped back the speaker&rsquo;s release from December to early 2018.</li><li>CIRP data says Amazon&rsquo;s Alexa has sold about 15M units in the two years since its launch.</li><li>The Bloomberg piece dives into the development history of the HomePod, which focuses more on audio quality than being a virtual assistant. But with Sonos now making smart speakers with quality sound, HomePod will face a competitive market.</li><li>&rdquo;This is a huge missed opportunity,&rdquo; an Apple source tells Bloomberg.</li><li>Apple shares are&nbsp;<font color='green'>up 1.95%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3313270-apple-homepod-launch-delayed-next-year\" target=\"_blank\">Apple HomePod launch delayed until next year</a> (Nov. 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3313851\" data-linked=\"Bloomberg: Apple plans to ship 4M HomePod units next year\" data-tweet=\"$AAPL $SONO - Bloomberg: Apple plans to ship 4M HomePod units next year https://seekingalpha.com/news/3313851-bloomberg-apple-plans-to-ship-4m-homepod-units-next-year?source=tweet\" data-url=\"https://seekingalpha.com/news/3313851-bloomberg-apple-plans-to-ship-4m-homepod-units-next-year\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313849\" data-ts=\"1511278301\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIBB\" target=\"_blank\">HIBB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313849-buckingham-sells-rip-in-hibbett-sports\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buckingham sells the rip in Hibbett Sports</a></h4><ul><li>Hibbett Sports (NASDAQ:<a href='https://seekingalpha.com/symbol/HIBB' title='Hibbett Sports, Inc.'>HIBB</a>) had&nbsp;<font color='green'>bounced more than 20%&nbsp;</font>since reporting its Q3 less than a week ago.</li><li>The e-commerce concerns and Nike headwinds that had previously roughed up the stock haven't gone anywhere, though, says analyst Eric Tracey, downgrading to Underperform from Neutral.</li><li>Source: Bloomberg</li><li>Shares&nbsp;<font color='red'>down 6.8%</font>&nbsp;today and&nbsp;<font color='red'>51.5%&nbsp;</font>YTD.</li></ul><div class=\"tiny-share-widget\" data-id=\"3313849\" data-linked=\"Buckingham sells the rip in Hibbett Sports\" data-tweet=\"$HIBB - Buckingham sells the rip in Hibbett Sports https://seekingalpha.com/news/3313849-buckingham-sells-rip-in-hibbett-sports?source=tweet\" data-url=\"https://seekingalpha.com/news/3313849-buckingham-sells-rip-in-hibbett-sports\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313836\" data-ts=\"1511277168\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CXRX-OLD\" target=\"_blank\">CXRX-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313836-uk-competition-watchdog-focusing-on-concordias-liothyronine-in-ongoing-inquiry-shares-down-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UK competition watchdog focusing on Concordia&#39;s liothyronine in ongoing inquiry; shares down 1%</a></h4><ul><li>In a <a href=\"https://seekingalpha.com/pr/17008010-concordia-international-corp-comments-cma-statement-objections-related-liothyronine\" target=\"_blank\">statement</a>, Concordia International (<a href='https://seekingalpha.com/symbol/CXRX-OLD' title='Concordia International Corp'>CXRX-OLD</a>) says the UK Competition and Markets Authority &#40;CMA&#41; has issued a preliminary opinion about possible violations of competition law committed by Cinven, the former owners of the company's international unit Amdipharm Mercury Limited, related to three products, including liothyronine tablets.</li><li>The CMA is apparently prioritizing liothyronine as it has placed to other two unnamed products on a slower investigative track and a non-priority track, respectively.</li><li>Concordia also announces that it has commenced court proceedings aimed at realigning its capital structure under Canadian law. The action constitutes a default under each of its agreements covering its 9.00% senior secured notes, 9.50% unsecured notes and currency swaps but the it is protected from legal action from creditors under the Canada Business Corporations Act. The company says it is advancing talks with creditors to reach mutually acceptable decisions on the matter.</li><li>Shares are off&nbsp;<font color='red'>1%</font>&nbsp;on light volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3300355-uk-competition-watchdog-launches-new-inquiry-pharmaceutical-arena-concordia-involved\" target=\"_blank\">UK competition watchdog launches new inquiry into pharmaceutical arena, Concordia involved</a> (Oct. 11)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302637-concordia-use-court-proceeding-restructure-debt-trading-resume-shortly\" target=\"_blank\">Concordia to use court proceeding to restructure debt; trading to resume shortly</a> (Oct. 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3313836\" data-linked=\"UK competition watchdog focusing on Concordia&#39;s liothyronine in ongoing inquiry; shares down 1%\" data-tweet=\"$CXRX-OLD - UK competition watchdog focusing on Concordia&#39;s liothyronine in ongoing inquiry; shares down 1% https://seekingalpha.com/news/3313836-uk-competition-watchdog-focusing-on-concordias-liothyronine-in-ongoing-inquiry-shares-down-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3313836-uk-competition-watchdog-focusing-on-concordias-liothyronine-in-ongoing-inquiry-shares-down-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313834\" data-ts=\"1511276407\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTNR\" target=\"_blank\">PTNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313834-partner-communicationsplus-12-after-sharp-rise-in-q3-profit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Partner Communications +12% after sharp rise in Q3 profit</a></h4><ul>   <li>Partner Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/PTNR' title='Partner Communications Company Ltd.'>PTNR</a>) is <font color='green'>up 12%</font> in early U.S. trading after posting <a href=\"https://seekingalpha.com/news/3313713-partner-communication-reports-q3-results\" target=\"_blank\">Q3 earnings</a> where cellular subscribers rose for the second straight quarter and the company trimmed debt.</li>    <li>Revenues fell 2.7% to 826M shekels. Service revenues fell 5%, to 666M shekels, but equipment revenues rose 6% to 160M shekels.</li>    <li>Profit rose 184%, meanwhile, to 54M shekels, about $15M.</li>    <li>EBITDA of 239M shekels ($67.8M) beat an expected 203M shekels (one estimate).</li>    <li>Adjusted free cash flow came to 202M shekels.</li>    <li>Net debt fell below 1B shekels, to 887M shekels.</li>    <li><a href=\"www.partner.co.il/en/Investors-Relations/lobby/\" target=\"_blank\">Conference call</a> to come at 10 a.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17008005-partner-communications-reports-third-quarter-2017-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3313834\" data-linked=\"Partner Communications +12% after sharp rise in Q3 profit\" data-tweet=\"$PTNR - Partner Communications +12% after sharp rise in Q3 profit https://seekingalpha.com/news/3313834-partner-communicationsplus-12-after-sharp-rise-in-q3-profit?source=tweet\" data-url=\"https://seekingalpha.com/news/3313834-partner-communicationsplus-12-after-sharp-rise-in-q3-profit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313833\" data-ts=\"1511276373\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QD\" target=\"_blank\">QD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313833-qudian-moves-quickly-buyback-announcement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qudian moves quickly with buyback announcement</a></h4><ul><li>Its shares plunging on report of a regulatory crackdown on China's online micro-lenders, Qudian (NYSE:<a href='https://seekingalpha.com/symbol/QD' title='Qudian, Inc.'>QD</a>) announces a buyback plan for up to $100M worth of its ADS over the next year.</li><li>CEO Min Luo: \"We continue to experience high demand from our customers and see exceptional growth opportunities on the horizon.\"</li><li>Source: <a href=\"https://seekingalpha.com/pr/17008572-qudian-inc-announces-us-100-million-share-repurchase-program\" target=\"_blank\">Press Release</a></li><li>Shares have bounced off the lows,&nbsp;<font color='red'>now down 11%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3313809-tightened-regulations-slam-chinese-online-lenders\" target=\"_blank\">Tightened regulations slam Chinese online lenders</a> (Nov. 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3313833\" data-linked=\"Qudian moves quickly with buyback announcement\" data-tweet=\"$QD - Qudian moves quickly with buyback announcement https://seekingalpha.com/news/3313833-qudian-moves-quickly-buyback-announcement?source=tweet\" data-url=\"https://seekingalpha.com/news/3313833-qudian-moves-quickly-buyback-announcement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>66&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313831\" data-ts=\"1511276208\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPA\" target=\"_blank\">SPA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313831-sparton-announces-cfius-review-completion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sparton announces CFIUS review completion</a></h4><ul><li>        Sparton (NYSE:<a href='https://seekingalpha.com/symbol/SPA' title='Sparton Corporation'>SPA</a>) <a href=\"https://seekingalpha.com/pr/17008373-sparton-announces-completion-cfius-process\" target=\"_blank\">announces</a> that the Committee on Foreign Investments in the United States &#40;CFIUS&#41; completed its review.</li><li>               CFIUS evaluates acquisitions for potential national security concerns. Sparton says the committee found no unresolved concerns with the proposed acquisition of Sparton by Ultra Electronics.&nbsp;</li><li>               Sparton shares are&nbsp;<font color='green'>up 1.13%</font>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3313831\" data-linked=\"Sparton announces CFIUS review completion\" data-tweet=\"$SPA - Sparton announces CFIUS review completion https://seekingalpha.com/news/3313831-sparton-announces-cfius-review-completion?source=tweet\" data-url=\"https://seekingalpha.com/news/3313831-sparton-announces-cfius-review-completion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313829\" data-ts=\"1511275757\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSTI\" target=\"_blank\">SSTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313829-shotspotter-targeted-mox-shares-down-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ShotSpotter targeted by Mox; shares down 9%</a></h4><ul><li>The company sells a program to local governments (with Federal subsidies) \"that simply doesn't work,\" <a href=\"https://twitter.com/MoxReports\" target=\"_blank\">says MoxReports</a>.</li><li>Internal memos, he says. show the company using aggressive tactics to thwart FOIA requests for data which would show futility.</li><li>Lockup for the recently IPO'd company expires on Dec. 8.</li><li><a href='https://seekingalpha.com/symbol/SSTI' title='ShotSpotter'>SSTI</a>&nbsp;<font color='red'>-9%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3313829\" data-linked=\"ShotSpotter targeted by Mox; shares down 9%\" data-tweet=\"$SSTI - ShotSpotter targeted by Mox; shares down 9% https://seekingalpha.com/news/3313829-shotspotter-targeted-mox-shares-down-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3313829-shotspotter-targeted-mox-shares-down-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313828\" data-ts=\"1511275632\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASYS\" target=\"_blank\">ASYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313828-amtech-systemsplus-2-after-q4-beats-upside-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amtech Systems +2% after Q4 beats, upside guidance</a></h4><ul><li>        Amtech Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/ASYS' title='Amtech Systems, Inc.'>ASYS</a>) shares are&nbsp;<font color='green'>up nearly 2%</font>&nbsp;after Q4 results that beat revenue and EPS estimates and featured an upside guidance.</li><li>                  Q1 guidance has revenue from $60M to $70M compared to the $49.19M consensus.    </li><li>               Key metrics: Customer orders, $27.6M; Solar orders, $9.6M; quarter-end backlog, $102.4M; book-to-bill ratio, 0.5:1; unrestricted cash, $51.1M.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17007789-amtech-reports-fourth-quarter-fiscal-2017-results\" target=\"_blank\">Press release </a>&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3313622-amtech-beats-0_42-beats-revenue\" target=\"_blank\">Amtech beats by $0.42, beats on revenue</a> (Nov. 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3313828\" data-linked=\"Amtech Systems +2% after Q4 beats, upside guidance\" data-tweet=\"$ASYS - Amtech Systems +2% after Q4 beats, upside guidance https://seekingalpha.com/news/3313828-amtech-systemsplus-2-after-q4-beats-upside-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3313828-amtech-systemsplus-2-after-q4-beats-upside-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313827\" data-ts=\"1511275362\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOV\" target=\"_blank\">MOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313827-on-movados-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Movado&#39;s Q3</a></h4><ul><li>Movado (<a href='https://seekingalpha.com/symbol/MOV' title='Movado Group, Inc.'>MOV</a> <font color='green'>+14.7%</font>) reports net sales rose 5.4%&nbsp;on a constant currency basis in <a href=\"https://seekingalpha.com/pr/17008113-movado-group-inc-announces-third-quarter-results\" target=\"_blank\">Q3</a>.</li><li>Gross margin rate +10 bps to 54.9%, primarily the result of a reduction of certain fixed costs and favorable changes in foreign currency exchange rates</li><li>Adjusted operating margin rate improved 30 bps to 17.6%.</li><li>Inventory +0.3% Y/Y to $169.87M.</li><li><b>FY2018 Guidance</b>: Net sales: $550M to $555M; Operating income: ~$58M to $60M; Tax rate: 30%; Net income: ~$39.7M to $41M; Diluted EPS: $1.70 to $1.75.</li></ul><div class=\"tiny-share-widget\" data-id=\"3313827\" data-linked=\"More on Movado&#39;s Q3\" data-tweet=\"$MOV - More on Movado&#39;s Q3 https://seekingalpha.com/news/3313827-on-movados-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3313827-on-movados-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313823\" data-ts=\"1511274462\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BPMX\" target=\"_blank\">BPMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313823-biopharmx-prices-equity-offering-shares-down-35-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioPharmX prices equity offering; shares down 35% premarket</a></h4><ul><li>Nano cap BioPharmX (NYSEMKT:<a href='https://seekingalpha.com/symbol/BPMX' title='BioPharmX Corporation'>BPMX</a>) is down&nbsp;<font color='red'>35%</font>&nbsp;premarket on robust volume in response to its<a href=\"https://seekingalpha.com/pr/17008548-biopharmx-corporation-announces-pricing-public-offering\" target=\"_blank\"> public offering</a> of 73.5M shares of common stock and accompanying warrants at a combined price of $0.15.</li><li>Each share of common stock will include a Series A warrant to purchase one share of common and one Series B warrant to purchase one share of common.</li><li>Each five-year Series A warrant is immediately exercisable at $0.20 per common share.</li><li>Each Series B warrant is immediately exercisable at $0.25 per common share and will expire on the earlier of the 21st trading day after the company issues a press release announcing a license or collaboration agreement to fund Phase 3 studies of BPX-01 or 18 months from the date of issuance.</li><li>Gross proceeds should be ~$11M. Net proceeds will fund further clinical development of BPX-04, working capital and general corporate purposes. Closing date is November 24.</li><li>Yesterday's close was $0.19.</li></ul><div class=\"tiny-share-widget\" data-id=\"3313823\" data-linked=\"BioPharmX prices equity offering; shares down 35% premarket\" data-tweet=\"$BPMX - BioPharmX prices equity offering; shares down 35% premarket https://seekingalpha.com/news/3313823-biopharmx-prices-equity-offering-shares-down-35-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3313823-biopharmx-prices-equity-offering-shares-down-35-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313819\" data-ts=\"1511274112\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVXL\" target=\"_blank\">AVXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313819-anavex-up-5-premarket-on-positive-data-on-sigmaminus-1-agonists\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anavex up 5% premarket on positive data on sigma-1 agonists</a></h4><ul><li>Thinly traded micro cap Anavex Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/AVXL' title='Anavex Life Sciences Corp.'>AVXL</a>) perks up&nbsp;<font color='green'>5%</font>&nbsp;premarket on light volume on the heels of <a href=\"https://seekingalpha.com/pr/17008159-anavex-life-sciences-reports-newly-published-data-alzheimers-disease-research-demonstrate\" target=\"_blank\">new data</a> published in <em>Neurotoxicity Research</em> supporting the neuroprotective aspects of sigma-1 agonists, including pipeline candidates ANAVEX 2-73, ANAVEX 1-41 and ANAVEX 3-71.</li><li>The research confirmed the antioxidant effect and protection of mitochondrial function of sigma-1 agonists in degenerative CNS disorders. For example, oxidative damage occurs in the brains of Alzheimer's disease &#40;AD&#41; sufferers before the appearance of amyloid plaques.</li><li>Another recent publication in <em>Behavioral Brain Research</em> showed the absence of sigma-1 receptor function exacerbates amyloid toxicity and increases learning impairments in AD mouse models.</li></ul><div class=\"tiny-share-widget\" data-id=\"3313819\" data-linked=\"Anavex up 5% premarket on positive data on sigma-1 agonists\" data-tweet=\"$AVXL - Anavex up 5% premarket on positive data on sigma-1 agonists https://seekingalpha.com/news/3313819-anavex-up-5-premarket-on-positive-data-on-sigmaminus-1-agonists?source=tweet\" data-url=\"https://seekingalpha.com/news/3313819-anavex-up-5-premarket-on-positive-data-on-sigmaminus-1-agonists\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313815\" data-ts=\"1511273660\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313815-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/CLSN' title='Celsion Corporation'>CLSN</a> <font color='green'>+61%</font>&nbsp;on up move ahead of <a href=\"https://seekingalpha.com/news/3313659-celsion-builds-move-ahead-thermodox-study-data-shares-ahead-20-percent-hours\" target=\"_blank\">ThermoDox study</a> data and <a href=\"https://seekingalpha.com/news/3313793-premarket-analyst-action-healthcare\" target=\"_blank\">positive</a> analyst action.</li><li><a href='https://seekingalpha.com/symbol/KTOV' title='Kitov Pharma Ltd.'>KTOV</a> <font color='green'>+18%</font>.</li><li><a href='https://seekingalpha.com/symbol/CMCM' title='Cheetah Mobile Inc.'>CMCM</a> <font color='green'>+16%</font>&nbsp;on Q3 <a href=\"https://seekingalpha.com/news/3313739-cheetah-mobile-beats-0_08-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/AXU' title='Alexco Resource Corporation'>AXU</a> <font color='green'>+10%.</font></li><li><a href='https://seekingalpha.com/symbol/EKSO' title='Ekso Bionics Holdings, Inc.'>EKSO</a> <font color='green'>+10%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/news/3313774-ekso-bionics-move\" target=\"_blank\">deal</a>&nbsp;with Ford.</li><li><a href='https://seekingalpha.com/symbol/PANW' title='Palo Alto Networks'>PANW</a> <font color='green'>+9%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3313620-palo-alto-networks-beats-0_05-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/MLNX' title='Mellanox Technologies, Ltd.'>MLNX</a> <font color='green'>+8%</font>&nbsp;as Starboard Value&nbsp;<a href=\"https://seekingalpha.com/news/3313689-starboard-value-discloses-10_7-percent-stake-mellanox-wants-explore-sale\" target=\"_blank\">discloses taking a 10.7% stake</a>&nbsp;on the company.&nbsp;</li><li><a href='https://seekingalpha.com/symbol/ASYS' title='Amtech Systems, Inc.'>ASYS</a> <font color='green'>+6%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3313622-amtech-beats-0_42-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color='green'>+6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3313813-ak-steel-plus-6-percent-credit-suisse-upgrades-sees-margin-expansion\" target=\"_blank\">upgrade</a> by Credit Suisse.</li><li><a href='https://seekingalpha.com/symbol/LPL' title='LG Display Co., Ltd.'>LPL</a> <font color='green'>+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3313815\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$CLSN $KTOV $CMCM - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3313815-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3313815-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313814\" data-ts=\"1511273569\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313814-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/CYTK' title='Cytokinetics, Incorporated'>CYTK</a>&nbsp;<font color='red'>-34%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17008198-cytokinetics-announces-negative-results-vitality-als\" target=\"_blank\">announcing</a> negative results from VITALITY-ALS.</li><li><a href='https://seekingalpha.com/symbol/QD' title='Qudian, Inc.'>QD</a>&nbsp;<font color='red'>-27%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3313809-tightened-regulations-slam-chinese-online-lenders\" target=\"_blank\">tightened</a> regulations.</li><li><a href='https://seekingalpha.com/symbol/ACST' title='Acasti Pharma, Inc.'>ACST</a> <font color='red'>-19%</font>.</li><li><a href='https://seekingalpha.com/symbol/SIG' title='Signet Jewelers Limited'>SIG</a>&nbsp;<font color='red'>-17%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3313751-signet-beats-0_05-misses-revenue\" target=\"_blank\">Q3 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/DSW' title='DSW Inc.'>DSW</a>&nbsp;<font color='red'>-14%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3313747-dsw-misses-0_08-misses-revenue\" target=\"_blank\">Q3 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/YRD' title='Yirendai LTD.'>YRD</a>&nbsp;<font color='red'>-8%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/news/3313809-tightened-regulations-slam-chinese-online-lenders\" target=\"_blank\">tightened</a>&nbsp;regulations.</li><li><a href='https://seekingalpha.com/symbol/VIPS' title='Vipshop Holdings'>VIPS</a>&nbsp;<font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3313613-vipshop-holdings-eps-line-beats-revenue\" target=\"_blank\">Q3 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/ZTO' title='ZTO Express'>ZTO</a>&nbsp;<font color='red'>-7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3313671-zto-express-eps-line-beats-revenue\" target=\"_blank\">Q3 earnings</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3313814\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$CYTK $QD $ACST - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3313814-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3313814-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313813\" data-ts=\"1511273368\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKS\" target=\"_blank\">AKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313813-ak-steelplus-6-credit-suisse-upgrades-sees-margin-expansion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AK Steel +6% as Credit Suisse upgrades, sees margin expansion</a></h4><ul>     <li>AK Steel (NYSE:<a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a>)&nbsp;<font color='green'>+5.8%</font> premarket as Credit Suisse <a href=\"https://www.streetinsider.com/Analyst+Comments/Credit+Suisse+Upgrades+AK+Steel+%28AKS%29+to+Outperform%3B+21%25+2018+FCF+Yield+and+Near+Term+Catalysts/13529435.html\" target=\"_blank\">upgrades</a> shares to Outperform from Neutral with a $7 price target.</li><li>The Credit Suisse steel analyst team expects <a href=\"https://twitter.com/thenotablecalls/status/932968293362741249\" target=\"_blank\">material expansion in margins</a> and 21% free cash flow yield in 2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3313813\" data-linked=\"AK Steel +6% as Credit Suisse upgrades, sees margin expansion\" data-tweet=\"$AKS - AK Steel +6% as Credit Suisse upgrades, sees margin expansion https://seekingalpha.com/news/3313813-ak-steelplus-6-credit-suisse-upgrades-sees-margin-expansion?source=tweet\" data-url=\"https://seekingalpha.com/news/3313813-ak-steelplus-6-credit-suisse-upgrades-sees-margin-expansion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313812\" data-ts=\"1511273225\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARDX\" target=\"_blank\">ARDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313812-ardelyx-prepares-to-launch-second-late-stage-study-of-hyperphosphatemia-med-tenapanor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ardelyx prepares to launch second late-stage study of hyperphosphatemia med tenapanor, development of hyperkalemia candidate RDX7675 terminated; shares up 7% premarket</a></h4><ul><li>Ardelyx (NASDAQ:<a href='https://seekingalpha.com/symbol/ARDX' title='Ardelyx'>ARDX</a>) is up&nbsp;<font color='green'>7%</font>&nbsp;premarket on modest volume on the heels of its <a href=\"https://seekingalpha.com/pr/17008094-ardelyx-announces-updated-development-path-cardiorenal-pipeline\" target=\"_blank\">announcement </a>that enrollment will begin shortly in a second Phase 3 study assessing lead candidate tenapanor for the treatment of hyperphosphatemia (excess phosphate in the blood) in end-stage renal disease patients on dialysis. Based on FDA feedback, the new trial will incorporate an active control arm for safety assessment only.</li><li>The company also announces that it has terminated development of #2 candidate RDX7675 for hyperkalemia (excess potassium in the blood) due to an expected side effect of decreased serum bicarbonate that would limit its use in a chronic setting. It will transition its hyperkalemia development efforts to an earlier-stage small molecule program. Lower-than-normal serum bicarbonate leads to the <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543378/\" target=\"_blank\">progression </a>of chronic kidney disease.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3243501-ardelyx-selectively-reports-results-late-stage-study-show-treatment-effect-lead-product\" target=\"_blank\">Ardelyx selectively reports results from late-stage study to show treatment effect of lead product candidate tenapanor in ESRD patients with elevated serum phosphate</a> (Feb. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3313812\" data-linked=\"Ardelyx prepares to launch second late-stage study of hyperphosphatemia med tenapanor, development of hyperkalemia candidate RDX7675 terminated; shares up 7% premarket\" data-tweet=\"$ARDX - Ardelyx prepares to launch second late-stage study of hyperphosphatemia med tenapanor, development of hyperkalemia candidate RDX7675 terminated; shares up 7% premarket https://seekingalpha.com/news/3313812-ardelyx-prepares-to-launch-second-late-stage-study-of-hyperphosphatemia-med-tenapanor?source=tweet\" data-url=\"https://seekingalpha.com/news/3313812-ardelyx-prepares-to-launch-second-late-stage-study-of-hyperphosphatemia-med-tenapanor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313809\" data-ts=\"1511273076\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QD\" target=\"_blank\">QD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313809-tightened-regulations-slam-chinese-online-lenders\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tightened regulations slam Chinese online lenders</a></h4><ul><li>Beijing <a href=\"https://twitter.com/thenotablecalls/status/932954579842535425\" target=\"_blank\">has reportedly suspended</a> approvals for new online micro-lenders. On the face, it seems like this might be a positive for existing players as the move halts competition, but they're all down sharply.</li><li>Quidan (NYSE:<a href='https://seekingalpha.com/symbol/QD' title='Qudian, Inc.'>QD</a>)<font color='red'> -28%</font>, China Rapid Finance (NYSE:<a href='https://seekingalpha.com/symbol/XRF' title='China Rapid Finance'>XRF</a>)&nbsp;<font color='red'>-15%</font>, Yirendai (NYSE:<a href='https://seekingalpha.com/symbol/YRD' title='Yirendai LTD.'>YRD</a>)&nbsp;<font color='red'>-9.3%</font>, Hexindai (NASDAQ:<a href='https://seekingalpha.com/symbol/HX' title='Hexindai Inc.'>HX</a>)&nbsp;<font color='red'>-12.8%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3313809\" data-linked=\"Tightened regulations slam Chinese online lenders\" data-tweet=\"$QD $QD $XRF - Tightened regulations slam Chinese online lenders https://seekingalpha.com/news/3313809-tightened-regulations-slam-chinese-online-lenders?source=tweet\" data-url=\"https://seekingalpha.com/news/3313809-tightened-regulations-slam-chinese-online-lenders\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313804\" data-ts=\"1511272611\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSRGY\" target=\"_blank\">NSRGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313804-wells-fargo-mulls-nestle-hain-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo mulls Nestle/Hain merger</a></h4><ul><li>Nestle (<a href='https://seekingalpha.com/symbol/NSRGY' title='Nestle S.A. ADR'>OTCPK:NSRGY</a>) has the financial flexibility not to have to worry about leveraging up too much to purchase Hain Celestial (NASDAQ:<a href='https://seekingalpha.com/symbol/HAIN' title='The Hain Celestial Group, Inc.'>HAIN</a>), says analyst John Baumgartner.</li><li>Baumgartner considers Hain's $4.8B valuation as a fancy one, but Nestle's scale could allow it to pay a high price and not have to worry about any post-purchase growth disappointment.</li><li>Nestle earned $10.5B in 2016 vs. estimates for Hain to make $179M in fiscal 2018.</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3313605-hain-celestial-jumps-talk-nestle-interest\" target=\"_blank\">Hain Celestial jumps on talk of Nestle interest</a> (Nov. 20)</li><li>Hain is higher by&nbsp;<font color='green'>1.4%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3313804\" data-linked=\"Wells Fargo mulls Nestle/Hain merger\" data-tweet=\"$NSRGY $NSRGY $HAIN - Wells Fargo mulls Nestle/Hain merger https://seekingalpha.com/news/3313804-wells-fargo-mulls-nestle-hain-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/3313804-wells-fargo-mulls-nestle-hain-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313803\" data-ts=\"1511272564\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADI\" target=\"_blank\">ADI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313803-analog-devices-beats-q4-estimates-issues-upside-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analog Devices beats Q4 estimates, issues upside guidance</a></h4><ul><li>        Analog Devices (NASDAQ:<a href='https://seekingalpha.com/symbol/ADI' title='Analog Devices Inc.'>ADI</a>) shares are&nbsp;<font color='red'>down 0.10%</font>&nbsp;premarket after Q4 results beat on EPS and revenue. &nbsp;</li><li>        Q1 guidance has revenue from $1.44B to $1.54B (consensus: $1.45B) with EPS from $1.20 to $1.36 (consensus: $1.18).</li><li>               Key metrics: Gross margin, 69.5%; operating margin, 39.5%; operating expenses, $557.8M; cash and equivalents, $1.05B.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17008293-analog-devices-reports-fourth-quarter-fiscal-year-2017-results\" target=\"_blank\">Press release </a>&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3313780-analog-devices-beats-0_09-beats-revenue\" target=\"_blank\">Analog Devices beats by $0.09, beats on revenue</a> (Nov. 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3313803\" data-linked=\"Analog Devices beats Q4 estimates, issues upside guidance\" data-tweet=\"$ADI - Analog Devices beats Q4 estimates, issues upside guidance https://seekingalpha.com/news/3313803-analog-devices-beats-q4-estimates-issues-upside-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3313803-analog-devices-beats-q4-estimates-issues-upside-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313800\" data-ts=\"1511271978\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTRN\" target=\"_blank\">CTRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313800-on-citi-trends-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Citi Trends&#39; Q3</a></h4><ul><li>Citi Trends (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRN' title='Citi Trends, Inc.'>CTRN</a>)&nbsp;reports comparable-store sales rose 7.4% in <a href=\"https://seekingalpha.com/pr/17008109-citi-trends-announces-third-quarter-2017-results\" target=\"_blank\">Q3</a>.</li><li>Gross margin rate up 30 bps to 37.8%.</li><li>SG&amp;A expense rate improved 140 bps to 34.5%.</li><li>Inventory +1.9% to $$133.25M.</li><li>Store count +4 Q/Q to 549.</li></ul><div class=\"tiny-share-widget\" data-id=\"3313800\" data-linked=\"More on Citi Trends&#39; Q3\" data-tweet=\"$CTRN - More on Citi Trends&#39; Q3 https://seekingalpha.com/news/3313800-on-citi-trends-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3313800-on-citi-trends-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313796\" data-ts=\"1511271115\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBRL\" target=\"_blank\">CBRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313796-on-cracker-barrels-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Cracker Barrel&#39;s Q1</a></h4><ul>     <li>Cracker Barrel (NASDAQ:<a href='https://seekingalpha.com/symbol/CBRL' title='Cracker Barrel Old Country Store, Inc.'>CBRL</a>)&nbsp;reports comparable restaurant sales increased 0.2% in <a href=\"https://seekingalpha.com/pr/17008234-cracker-barrel-reports-results-first-quarter-fiscal-2018-comparable-store-sales-outperformed\" target=\"_blank\">Q1</a>,&nbsp;including a 2% increase in average check partially offset by a 1.8% decrease in&nbsp;store traffic.</li>     <li>Comparable retail sales fell 3.6%.</li>     <li>The average menu price increased ~2.2%.</li>     <li>Restaurant revenue grew 0.8% to $578.24M and retail revenue slipped 3.1% to $132.13M.</li>     <li>Operating margin rate down 70 bps to 10%.</li>     <li>Store count +8 Y/Y to 651.</li>     <li>The company expects Q2diluted EPS in the range of $2.15 to $2.25.</li>     <li><b>FY2018 Guidance</b>: Total revenue: ~$3.1B; Comparable store restaurant sales: +2% to +3%; Comparable store retail sales: ~flat; Depreciation expense: $95M to $100M; Net interest expense: $15M to $16M; Diluted&nbsp;EPS of $8.75 to $8.9; Operating margin rate: ~10.5%; Capex: ~$150M to $160M; Tax rate: 31% to 32%.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3313796\" data-linked=\"More on Cracker Barrel&#39;s Q1\" data-tweet=\"$CBRL - More on Cracker Barrel&#39;s Q1 https://seekingalpha.com/news/3313796-on-cracker-barrels-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3313796-on-cracker-barrels-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313793\" data-ts=\"1511271005\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLSN\" target=\"_blank\">CLSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313793-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Celsion (NASDAQ:<a href='https://seekingalpha.com/symbol/CLSN' title='Celsion Corporation'>CLSN</a>) initiated with Outperform rating and $9 (321% upside) price target by Oppenheimer based on the expected success of a Phase 3 study of ThermoDox combined with radiofrequency ablation in liver cancer patients (OPTIMA study). Shares are up&nbsp;<font color='green'>36%</font>&nbsp;premarket on robust volume.</li><li>GTx (NASDAQ:<a href='https://seekingalpha.com/symbol/GTXI' title='GTx, Inc.'>GTXI</a>) initiated with Outperform rating and $17 (55% upside) price target by Baird.</li><li>Sunesis Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SNSS' title='Sunesis Pharmaceuticals, Inc.'>SNSS</a>) initiated with Outperform rating and $7 (144% upside) price target by Oppenheimer. Shares up&nbsp;<font color='green'>8%</font>&nbsp;premarket.</li><li>Enanta Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ENTA' title='Enanta Pharmaceuticals, Inc.'>ENTA</a>) price target raised to $58 (16% upside) from $54 by RBC based on anticipated increased royalties from commercialization partner AbbVie and positive outlook for internal pipeline.</li><li>Align Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/ALGN' title='Align Technology, Inc.'>ALGN</a>) price target raised to $265 (4% upside) from $245 by Stifel.</li><li>Teladoc (NYSE:<a href='https://seekingalpha.com/symbol/TDOC' title='Teladoc Health, Inc.'>TDOC</a>) price target raised to $45 (48% upside) from $40 by Oppenheimer.</li><li>Incyte (NASDAQ:<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a>) price target lowered to $120 (21% upside) from $136 by RBC citing valuation.</li></ul><div class=\"tiny-share-widget\" data-id=\"3313793\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$CLSN $CLSN $ONCT - Premarket analyst action - healthcare https://seekingalpha.com/news/3313793-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3313793-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313784\" data-ts=\"1511269789\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPB\" target=\"_blank\">CPB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313784-campbell-soup-down-on-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Campbell Soup down on earnings miss</a></h4><ul>     <li>Campbell Soup (NYSE:<a href='https://seekingalpha.com/symbol/CPB' title='Campbell Soup Company'>CPB</a>)&nbsp;reports organic net sales fell 2% in <a href=\"https://seekingalpha.com/pr/17008177-campbell-reports-first-quarter-results\" target=\"_blank\">Q1</a>, reflecting lower volume.</li>     <li>Total volume and mix down 2% for the period.</li>     <li>Revenue by segments:&nbsp;Americas simple meals and beverages: $1.22B (-5%);&nbsp;Global biscuits and snacks: $709M&nbsp;(+3%);&nbsp;Campbell fresh: $234M&nbsp;(flat%).</li>     <li>Adjusted gross margin rate squeezed 210 bps to 36.5%, primarily driven by cost inflation and higher supply chain costs, as well as unfavorable mix.</li>     <li>Adjusted EBIT slipped 280 bps to 19.3%.</li>     <li><b>FY2018 Guidance</b>: Net sales: -2% to 0%; Adjusted EBIT: -4% to -2%; Adjusted EPS: $2.95 to $3.02 (-3% to -1%).</li>     <li>CPB&nbsp;<font color='red'>-8.77%</font>&nbsp;premarket.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3313784\" data-linked=\"Campbell Soup down on earnings miss\" data-tweet=\"$CPB - Campbell Soup down on earnings miss https://seekingalpha.com/news/3313784-campbell-soup-down-on-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3313784-campbell-soup-down-on-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313783\" data-ts=\"1511269707\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KTOV\" target=\"_blank\">KTOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313783-kitov-pharmaceuticals-up-20-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kitov Pharmaceuticals up 20% premarket</a></h4><ul><li>Kitov Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/KTOV' title='Kitov Pharma Ltd.'>KTOV</a>) jumps&nbsp;<font color='green'>20%</font>&nbsp;premarket on increased volume. No particular news accounts for the action other that an upgrade by nano cap uber-bull H.C. Wainwright to Buy with a $10 (408% upside) price target.</li><li>Last month, the company announced positive results from a Phase 3 study assessing lead candidate KIT-302's effect on renal function. Shares jumped on the news but completed a round-trip about 30 days later.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3304725-kitovs-kitminus-302-successful-late-stage-study-shares-ahead-14-percent\" target=\"_blank\">Kitov's KIT-302 successful in late-stage study; shares ahead 14%</a> (Oct. 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3313783\" data-linked=\"Kitov Pharmaceuticals up 20% premarket\" data-tweet=\"$KTOV - Kitov Pharmaceuticals up 20% premarket https://seekingalpha.com/news/3313783-kitov-pharmaceuticals-up-20-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3313783-kitov-pharmaceuticals-up-20-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313775\" data-ts=\"1511269176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APPN\" target=\"_blank\">APPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313775-suntrust-initiates-appian\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunTrust initiates Appian</a></h4><ul><li>        SunTrust <a href=\"https://markets.ft.com/data/equities/tearsheet/forecasts?s=APPN:NMQ\" target=\"_blank\">initiates</a> Appian (NASDAQ:<a href='https://seekingalpha.com/symbol/APPN' title='Appian Corp.'>APPN</a>) at Buy with a $28 price target.</li><li>               Latest analyst recommendations (via FT): 6 Hold.&nbsp;</li><li>                  Median price target: $22. &nbsp;   </li><li>               Appian shares are&nbsp;<font color='green'>up 0.25%</font>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3311662-appian-files-common-stock-offering-selling-shareholders\" target=\"_blank\">Appian files for common stock offering from selling shareholders</a> (Nov. 13)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3312797-appian-prices-follow-offering\" target=\"_blank\">Appian prices follow-on offering</a> (Nov. 16)</li></ul><div class=\"tiny-share-widget\" data-id=\"3313775\" data-linked=\"SunTrust initiates Appian\" data-tweet=\"$APPN - SunTrust initiates Appian https://seekingalpha.com/news/3313775-suntrust-initiates-appian?source=tweet\" data-url=\"https://seekingalpha.com/news/3313775-suntrust-initiates-appian\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313773\" data-ts=\"1511268959\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYTK\" target=\"_blank\">CYTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313773-cytokinetics-stops-developing-tirasemtiv-after-failed-late-stage-als-study-trading-halted\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cytokinetics stops developing tirasemtiv after failed late-stage ALS study; trading halted</a></h4><ul><li>Cytokinetics (NASDAQ:<a href='https://seekingalpha.com/symbol/CYTK' title='Cytokinetics, Incorporated'>CYTK</a>) is facing an ugly day after its <a href=\"https://seekingalpha.com/pr/17008198-cytokinetics-announces-negative-results-vitality-als\" target=\"_blank\">announcement </a>that a Phase 3 clinical trial, VITALITY-ALS, evaluating tirasemtiv in patients with amyotrophic lateral sclerosis &#40;ALS&#41; failed to achieve the primary endpoint of a change in slow vital capacity &#40;SVC&#41; at week 24 versus baseline. None of the secondary endpoints were met either.</li><li>The decline in SVC from baseline to week 24 was smaller in the treatment group compared to placebo and the largest differences were observed in the mid-dose and high-dose tirasemtiv cohorts but the differences were not statistically significant.</li><li>Serious adverse events were similar between the treatment and control groups. There were more discontinuations in the tirasemtiv cohorts due to tolerability issues.</li><li>CEO Robert Blum says, &ldquo;While we are deeply disappointed by the results of VITALITY-ALS, we remain committed to people with ALS who are fighting this devastating disease and who need new therapies to slow the decline of respiratory function and muscle strength that are key hallmarks of disease progression. We have decided to suspend the development of&nbsp;<em>tirasemtiv</em>. While we believe that VITALITY-ALS demonstrated pharmacologic activity for the mechanism of action, we also believe that limitations of&nbsp;<em>tirasemtiv</em>&nbsp;may be addressed with our next-generation fast skeletal muscle activator, CK-2127107.&nbsp; Based on previous Phase 1 clinical studies, we believe CK-2127107 will be better tolerated and potentially more effective than&nbsp;<em>tirasemtiv&nbsp;</em>in patients with ALS and look forward to Phase 2 trial results in 2018.</li><li>Complete results from VITALITY-ALS will be presented on December 8 at the International ALS/MND Symposium in Boston.</li><li>The company will host a conference call this morning at 8:30 am ET to discuss the data. Shares will resume trading at 8:00 am ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3203910-cytokinetics-completes-enrollment-late-stage-als-study-tirasemtiv-data-readout-expected-h2\" target=\"_blank\">Cytokinetics completes enrollment in late-stage ALS study of tirasemtiv, data readout expected in H2 2017</a> (Aug. 17, 2016)</li><li><strong>Update</strong>: Shares are down&nbsp;<font color='red'>27%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3313773\" data-linked=\"Cytokinetics stops developing tirasemtiv after failed late-stage ALS study; trading halted\" data-tweet=\"$CYTK - Cytokinetics stops developing tirasemtiv after failed late-stage ALS study; trading halted https://seekingalpha.com/news/3313773-cytokinetics-stops-developing-tirasemtiv-after-failed-late-stage-als-study-trading-halted?source=tweet\" data-url=\"https://seekingalpha.com/news/3313773-cytokinetics-stops-developing-tirasemtiv-after-failed-late-stage-als-study-trading-halted\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3313774\" data-ts=\"1511268859\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EKSO\" target=\"_blank\">EKSO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3313774-ekso-bionics-on-move\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ekso Bionics on the move</a></h4><ul><li>After <font color='green'>rising over 22%</font> yesterday, Ekso Bionics (NASDAQ:<a href='https://seekingalpha.com/symbol/EKSO' title='Ekso Bionics Holdings, Inc.'>EKSO</a>) is <font color='green'>up another 12%</font> this morning as more investors seem to take notice of the company's recent <a href=\"https://seekingalpha.com/news/3310991-ford-tests-bionic-auto-workers\" target=\"_blank\">deal</a> with Ford.</li><li>The automaker will be testing the EksoVest, an upper body exoskeleton, among its assembly line workers in two different U.S. factories.</li></ul><div class=\"tiny-share-widget\" data-id=\"3313774\" data-linked=\"Ekso Bionics on the move\" data-tweet=\"$EKSO - Ekso Bionics on the move https://seekingalpha.com/news/3313774-ekso-bionics-on-move?source=tweet\" data-url=\"https://seekingalpha.com/news/3313774-ekso-bionics-on-move\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}